0	Shared and unique determinants of the PROTEIN ( PROTEIN ) receptor are important for binding PROTEIN1PROTEIN2 ) receptor are important for binding PROTEIN and PROTEIN mimetic peptide .
0	Gel retardation and methylation interference assays show that PROTEIN1 is able to bind specifically to a site embedded within the two PROTEIN2 elements .
0	We studied the human PROTEIN1 ( PROTEIN2 ) /hIL-6R binding interface by a combination of molecular modelling and site-directed mutagenesis .
0	PROTEIN recognizes one FGFR isoform known as the PROTEIN IIIb isoform or PROTEIN1 receptor ( PROTEIN ) , whereas PROTEIN binds well to PROTEIN , PROTEIN , and PROTEIN but interacts poorly with PROTEIN2 .
1	We have shown previously that Phe93 in the extracellular domain of the PROTEIN ( PROTEIN ) receptor ( PROTEIN1 ) is crucial for binding PROTEIN2.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( EPO-binding protein or PROTEIN ) and no detectable binding to full-length mutant receptor expressed in COS cells .
0	PROTEIN encodes a novel 21 kd protein that is found in cyclin A , cyclin D1 , cyclin E , and PROTEIN1PROTEIN2 , and PROTEIN immunoprecipitates .
0	In vitro protein-protein interaction assays reveal that as observed with Drosophila PROTEIN , PROTEIN interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator viral protein 16 ( PROTEIN1 ) as well as with the general transcription factor PROTEIN2 .
0	Replacement of this loop with the homologous loop from PROTEIN dramatically reduced both the affinity of PROTEIN for PROTEIN and its biological potency but did not result in the ability to bind PROTEIN1PROTEIN2 for PROTEIN and its biological potency but did not result in the ability to bind PROTEIN .
0	PROTEIN is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN1 by cyclin A-Cdk2 , cyclin E-PROTEIN2 , cyclin D1-Cdk4 , and cyclin D2-Cdk4 complexes .
0	By using the growth factor dependent M-07e cell line , we found that both PROTEIN and PROTEIN1 ligands , namely : PROTEIN and PROTEIN2 , induce PROTEIN tyrosine phosphorylation .
1	We studied the human PROTEIN1 ( PROTEIN ) /PROTEIN2 binding interface by a combination of molecular modelling and site-directed mutagenesis .
0	We have shown previously that Phe93 in the extracellular domain of the PROTEIN ( PROTEIN ) receptor ( PROTEIN1 ) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( EPO-binding protein or PROTEIN2 ) and no detectable binding to full-length mutant receptor expressed in COS cells .
1	Cell surface PROTEIN1 formed complexes in vivo with actin-binding protein PROTEIN2 ( PROTEIN ) , which is known to form bridges between cell surface receptors and cytoskeleton and mediate cell adhesion and cell motility .
0	Expression of PROTEIN IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including PROTEIN , -2 , -4 , and -6 , while PROTEIN1PROTEIN2-expressing cells responded only to PROTEIN .
0	Transcription factor PROTEIN consists of TATA binding protein ( PROTEIN1PROTEIN2 ( PROTEIN ) and at least eight TBP-associated factors ( TAFs ) .
0	Two lines of evidence support the notion that PROTEIN and simian virus 40 T antigen have homologous PROTEIN1-binding properties : first , several mutated PROTEIN2 proteins that failed to bind to T also did not associate with PROTEIN ; and second , both T antigen and T peptide ( amino acids 101-118 ) were able to compete with PROTEIN for binding to PROTEIN .
0	PROTEIN ; these two complexes may alternatively link PROTEIN to PROTEIN1PROTEIN2 to mitogen-activated protein kinase .
0	These data demonstrate that the PROTEIN PROTEIN is the T-cell homologue of the cloned PROTEIN , and imply that the PROTEIN and PROTEIN1PROTEIN2 PROTEIN is the T-cell homologue of the cloned PROTEIN , and imply that the PROTEIN and PROTEIN PROTEIN have different extracellular domains .
0	PROTEIN1 is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by cyclin A-PROTEIN2 , cyclin E-Cdk2 , cyclin D1-Cdk4 , and cyclin D2-Cdk4 complexes .
0	Molecular cloning and expression of the 32-kDa subunit of human PROTEIN reveals interactions with PROTEIN and PROTEIN1PROTEIN2 and PROTEIN that mediate transcriptional activation .
1	We have shown previously that Phe93 in the extracellular domain of the PROTEIN ( PROTEIN ) receptor ( PROTEIN ) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN1 binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( EPO-binding protein or PROTEIN2 ) and no detectable binding to full-length mutant receptor expressed in COS cells .
0	PROTEIN1- and PROTEIN2-dependent PROTEIN surface expression correlates with the binding of an MHC class I leader peptide .
1	PROTEIN1 contains this primary site as well as a region that restricts interaction with PROTEIN2 .
1	Discrete protein interactions with the PROTEIN1/PROTEIN2 complex in SCF- and TPO-mediated myeloid cell proliferation .
0	PROTEIN1 recognizes one FGFR isoform known as the PROTEIN IIIb isoform or keratinocyte growth factor receptor ( PROTEIN ) , whereas PROTEIN binds well to PROTEIN , PROTEIN , and PROTEIN but interacts poorly with PROTEIN2 .
1	By using the growth factor dependent M-07e cell line , we found that both PROTEIN and PROTEIN ligands , namely : PROTEIN and PROTEIN1 , induce PROTEIN2 tyrosine phosphorylation .
1	A protein , sorting nexin-1 ( PROTEIN1 ) , was identified in a human cell line that bound to a region of the epidermal growth factor receptor ( PROTEIN2 ) containing the lysosomal targeting code .
0	The effect on PROTEIN1 transcriptional activity results , in part , from enhanced phosphorylation of the PROTEIN2 NH2-terminal activation domain .
0	PROTEIN recognizes one FGFR isoform known as the PROTEIN IIIb isoform or PROTEIN1 ( PROTEIN ) , whereas PROTEIN binds well to PROTEIN , PROTEIN , and PROTEIN2 but interacts poorly with PROTEIN .
0	Two potentially oncogenic cyclins , cyclin A and PROTEIN1 , share common properties of subunit configuration , tyrosine phosphorylation and physical association with the PROTEIN protein .Originally identified as a 'mitotic cyclin ' , cyclin A exhibits properties of growth factor sensitivity , susceptibility to viral subversion and association with a tumor-suppressor protein , properties which are indicative of an S-phase-promoting factor ( PROTEIN2 ) as well as a candidate proto-oncogene .
0	Shared and unique determinants of the PROTEIN ( PROTEIN ) receptor are important for binding PROTEIN and PROTEIN1PROTEIN2 ) receptor are important for binding PROTEIN and PROTEIN mimetic peptide .
0	These data demonstrate that the PROTEIN PROTEIN is the T-cell homologue of the cloned PROTEIN , and imply that the PROTEIN and PROTEIN1 PROTEIN2 have different extracellular domains .
0	By using the growth factor dependent M-07e cell line , we found that both PROTEIN and PROTEIN ligands , namely : PROTEIN1 and PROTEIN2 , induce PROTEIN tyrosine phosphorylation .
0	Shared and unique determinants of the PROTEIN ( PROTEIN ) receptor are important for binding PROTEIN and PROTEIN1PROTEIN2 are important for binding PROTEIN and PROTEIN mimetic peptide .
0	PROTEIN utilizes two different pools of adapter protein PROTEIN to link to PROTEIN1PROTEIN2 to link to PROTEIN .
0	Our results indicate that Phe93 and Phe205 are important for both PROTEIN and PROTEIN binding , Met150 is not important for PROTEIN binding but is critical for PROTEIN1PROTEIN2 binding but is critical for PROTEIN binding , and Thr151 is not important for binding either ligand .
0	We have shown previously that Phe93 in the extracellular domain of the PROTEIN ( PROTEIN ) receptor ( PROTEIN ) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN1 or PROTEIN2 ) and no detectable binding to full-length mutant receptor expressed in COS cells .
0	In order to characterize the signaling pathway through which PROTEIN regulates cell growth , L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms , PROTEIN IIIb and PROTEIN1 IIIc , that result from alternative splicing of exon III of the PROTEIN2 gene encoding the ligand binding domain .
0	We have shown previously that Phe93 in the extracellular domain of the PROTEIN1 ( PROTEIN ) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN2 binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( EPO-binding protein or PROTEIN ) and no detectable binding to full-length mutant receptor expressed in COS cells .
1	Our finding that PROTEIN1 directly interacts with RNA polymerase II subunit 5 ( PROTEIN2 ) , a common subunit of RNA polymerases , implies that PROTEIN directly modulates the function of RNA polymerase ( Cheong , J. H. , Yi , M. , Lin , Y. , and Murakami , S. ( 1995 ) EMBO J .
0	We have shown previously that Phe93 in the extracellular domain of the PROTEIN ( PROTEIN ) receptor ( PROTEIN ) is crucial for binding PROTEIN1.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN2 ( EPO-binding protein or PROTEIN ) and no detectable binding to full-length mutant receptor expressed in COS cells .
0	In order to characterize the signaling pathway through which PROTEIN1 regulates cell growth , L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms , PROTEIN IIIb and PROTEIN2 , that result from alternative splicing of exon III of the PROTEIN gene encoding the ligand binding domain .
0	We have shown previously that Phe93 in the extracellular domain of the PROTEIN1 ( PROTEIN ) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN2 ( EPO-binding protein or PROTEIN ) and no detectable binding to full-length mutant receptor expressed in COS cells .
0	PROTEIN is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by cyclin A-Cdk2 , cyclin E-Cdk2 , PROTEIN1-Cdk4 , and cyclin D2-PROTEIN2 complexes .
0	The interaction between PROTEIN ( PROTEIN1 ) and PROTEIN receptor ( PROTEIN2 ) is the initial and most specific step in the PROTEIN signaling pathway .
1	Following this hypothesis , we altered in PROTEIN1 and PROTEIN2 residues predicted to reside in the contact region and to interact with each other .
1	PROTEIN1 recognizes one FGFR isoform known as the PROTEIN IIIb isoform or keratinocyte growth factor receptor ( PROTEIN2 ) , whereas PROTEIN binds well to PROTEIN , PROTEIN , and PROTEIN but interacts poorly with PROTEIN .
1	The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ( PROTEIN1 , FADD/MORT , RIP , FLICE/MACH , and TRAFs ) associated with both of the PROTEIN and PROTEIN2 forms of the TNF receptor and with other members of the TNF receptor superfamily .
0	Two lines of evidence support the notion that PROTEIN and simian virus 40 T antigen have homologous Rb-binding properties : first , several mutated PROTEIN proteins that failed to bind to T also did not associate with PROTEIN ; and second , both T antigen and T peptide ( amino acids 101-118 ) were able to compete with PROTEIN1 for binding to PROTEIN2 .
0	By contrast the PROTEIN exchanger factor ( PROTEIN ) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/PROTEIN1PROTEIN2 exchanger factor ( PROTEIN ) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and Grb2/c-Cbl are present in different complexes .
0	Cell surface PROTEIN formed complexes in vivo with actin-binding protein PROTEIN1 ( PROTEIN2 ) , which is known to form bridges between cell surface receptors and cytoskeleton and mediate cell adhesion and cell motility .
0	PROTEIN is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN1-Cdk2 , PROTEIN2-Cdk2 , cyclin D1-Cdk4 , and cyclin D2-Cdk4 complexes .
0	We have shown previously that Phe93 in the extracellular domain of the PROTEIN ( PROTEIN1 ) receptor ( PROTEIN ) is crucial for binding PROTEIN2.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( EPO-binding protein or PROTEIN ) and no detectable binding to full-length mutant receptor expressed in COS cells .
0	We have shown previously that Phe93 in the extracellular domain of the PROTEIN1 ( PROTEIN2 ) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( EPO-binding protein or PROTEIN ) and no detectable binding to full-length mutant receptor expressed in COS cells .
1	PROTEIN recognizes one FGFR isoform known as the PROTEIN IIIb isoform or keratinocyte growth factor receptor ( PROTEIN ) , whereas PROTEIN1 binds well to PROTEIN , PROTEIN , and PROTEIN2 but interacts poorly with PROTEIN .
0	Thus , Phe93 and Phe205 are important binding determinants for both PROTEIN1 and PROTEIN2 , even though these ligands share no sequence or structural homology , suggesting that these residues may represent a minimum epitope on the PROTEIN for productive ligand binding .
0	In order to characterize the signaling pathway through which PROTEIN regulates cell growth , L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms , PROTEIN IIIb and PROTEIN1 , that result from alternative splicing of exon III of the PROTEIN2 gene encoding the ligand binding domain .
1	PROTEIN1 binds to the PROTEIN2 transactivation domain and phosphorylates it on Ser-63 and Ser-73 .
1	In these cells the adaptor protein PROTEIN1 constitutively binds a substantial fraction of PROTEIN2 through the N-terminal SH3 domain .
0	We demonstrate that PROTEIN1 surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the transporter associated with antigen processing ( PROTEIN ) and PROTEIN , and that PROTEIN2 expression is TAP-dependent and tapasin-dependent .
0	Shared and unique determinants of the PROTEIN1 ( PROTEIN2 ) receptor are important for binding PROTEIN and PROTEIN mimetic peptide .
0	Replacement of this loop with the homologous loop from PROTEIN dramatically reduced both the affinity of PROTEIN for PROTEIN and its biological potency but did not result in the ability to bind PROTEIN1PROTEIN2 and its biological potency but did not result in the ability to bind PROTEIN .
0	Two potentially oncogenic cyclins , PROTEIN1 and cyclin D1 , share common properties of subunit configuration , tyrosine phosphorylation and physical association with the PROTEIN protein .Originally identified as a 'mitotic cyclin ' , cyclin A exhibits properties of growth factor sensitivity , susceptibility to viral subversion and association with a tumor-suppressor protein , properties which are indicative of an S-phase-promoting factor ( PROTEIN2 ) as well as a candidate proto-oncogene .
0	We have shown previously that Phe93 in the extracellular domain of the PROTEIN ( PROTEIN1PROTEIN2 ( PROTEIN ) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( EPO-binding protein or PROTEIN ) and no detectable binding to full-length mutant receptor expressed in COS cells .
1	PROTEIN is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by cyclin A-Cdk2 , cyclin E-Cdk2 , PROTEIN1-PROTEIN2 , and cyclin D2-Cdk4 complexes .
0	Functional studies in Jurkat T lymphocytic cells point to the importance of both the PROTEIN and PROTEIN binding sites in PROTEIN1PROTEIN2 binding sites in PROTEIN mediated repression of HIV-1 promoter , in vivo .
0	By contrast the PROTEIN exchanger factor ( PROTEIN ) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/PROTEIN1PROTEIN2 ) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and Grb2/c-Cbl are present in different complexes .
0	By contrast stimulation with PROTEIN leads to the formation of a PROTEIN1PROTEIN2 leads to the formation of a PROTEIN complex containing PROTEIN .
0	Moreover we found that , upon PROTEIN1 stimulation , the PROTEIN2/c-Cbl complex recruits PROTEIN , probably via PROTEIN .
1	Remarkably , Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the PROTEIN1 bound to an EPO-mimetic peptide ( PROTEIN2 ) , suggesting that Phe93 is also important for PROTEIN binding .
0	By contrast the PROTEIN exchanger factor ( PROTEIN ) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and Grb2/PROTEIN1PROTEIN2 immunoprecipitates suggesting that Grb2/Sos1 and Grb2/c-Cbl are present in different complexes .
0	In agreement , mAb to the previously cloned PROTEIN were found to stain unstimulated T cells that express only the PROTEIN PROTEIN1PROTEIN2 PROTEIN but not T-cell clones that express predominantly the PROTEIN PROTEIN .
0	By contrast the PROTEIN exchanger factor ( PROTEIN ) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and Grb2/PROTEIN1PROTEIN2 exchanger factor ( PROTEIN ) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and Grb2/c-Cbl are present in different complexes .
0	Two lines of evidence support the notion that PROTEIN and PROTEIN1 have homologous Rb-binding properties : first , several mutated PROTEIN proteins that failed to bind to T also did not associate with PROTEIN ; and second , both T antigen and T peptide ( amino acids 101-118 ) were able to compete with PROTEIN for binding to PROTEIN2 .
0	In the present study we evaluated tyrosine phosphorylation of PROTEIN and the interaction of the PROTEIN1/c-Cbl complex with signaling proteins upon activation of non-tyrosine ( PROTEIN ) and tyrosine kinase ( PROTEIN2 ) receptors leading to myeloid cell proliferation .
0	Here , we demonstrate that PROTEIN1 may regulate the activity of the HIV-1 long terminal repeat through its ability to bind sequences in the PROTEIN2 enhancer region and to interact with the PROTEIN subunit , PROTEIN .
0	In agreement , mAb to the previously cloned PROTEIN were found to stain unstimulated T cells that express only the PROTEIN PROTEIN1 but not T-cell clones that express predominantly the PROTEIN PROTEIN2 .
0	Two potentially oncogenic cyclins , cyclin A and cyclin D1 , share common properties of subunit configuration , tyrosine phosphorylation and physical association with the PROTEIN1 protein .Originally identified as a 'mitotic cyclin ' , cyclin A exhibits properties of growth factor sensitivity , susceptibility to viral subversion and association with a tumor-suppressor protein , properties which are indicative of an S-phase-promoting factor ( PROTEIN2 ) as well as a candidate proto-oncogene .
0	We have shown previously that Phe93 in the extracellular domain of the PROTEIN ( PROTEIN1 ) receptor ( PROTEIN ) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN2 binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( EPO-binding protein or PROTEIN ) and no detectable binding to full-length mutant receptor expressed in COS cells .
1	Cross-family dimerization of transcription factors PROTEIN1/PROTEIN2 and ATF/CREB alters DNA binding specificity .
0	PROTEIN is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by cyclin A-Cdk2 , cyclin E-PROTEIN1 , cyclin D1-Cdk4 , and cyclin D2-PROTEIN2 complexes .
0	We have shown previously that Phe93 in the extracellular domain of the PROTEIN ( PROTEIN ) receptor ( PROTEIN ) is crucial for binding PROTEIN1.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( EPO-binding protein or PROTEIN2 ) and no detectable binding to full-length mutant receptor expressed in COS cells .
0	In vitro protein-protein interaction assays reveal that as observed with Drosophila PROTEIN , PROTEIN interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator PROTEIN1 ( PROTEIN ) as well as with the general transcription factor PROTEIN2 .
1	Some PROTEIN1 substitution mutants , which had severely impaired transacting activity , exhibited reduced binding affinity with either PROTEIN or PROTEIN2 in a mutually exclusive manner , suggesting that PROTEIN transactivation requires the interactions of both PROTEIN and PROTEIN .
0	PROTEIN ; these two complexes may alternatively link PROTEIN1PROTEIN2 ; these two complexes may alternatively link PROTEIN to mitogen-activated protein kinase .
1	In normal human cells , but not in many tumour cells , PROTEIN1 exists in a quaternary complex with a cyclin , a CDK , and the PROTEIN2 ( PROTEIN ) .
0	Remarkably , Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the PROTEIN bound to an EPO-mimetic peptide ( PROTEIN ) , suggesting that Phe93 is also important for PROTEIN1PROTEIN2 ( PROTEIN ) , suggesting that Phe93 is also important for PROTEIN binding .
0	By contrast the PROTEIN exchanger factor ( PROTEIN ) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and Grb2/PROTEIN1PROTEIN2/c-Cbl are present in different complexes .
0	In this study the origin and function of the PROTEIN1 and PROTEIN2 molecules have been investigated .
0	In order to characterize the signaling pathway through which PROTEIN regulates cell growth , L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms , PROTEIN IIIb and PROTEIN1PROTEIN2 , that result from alternative splicing of exon III of the PROTEIN gene encoding the ligand binding domain .
1	Delineation of the binding regions of these three proteins revealed that PROTEIN1 , PROTEIN2 , and PROTEIN each has two binding regions for the other two proteins .
0	The reciprocal loop replacement mutant ( FGF2-L4/7 ) retained PROTEIN like affinity for PROTEIN and for PROTEIN1PROTEIN2-L4/7 ) retained PROTEIN like affinity for PROTEIN and for PROTEIN .
0	The correlation between PROTEIN and MHC class I surface expression might be relevant to the function of HLA-E. Our results also show that , although these PROTEIN binding peptides are derived from signal sequences , they may be released back into the cytosol and subsequently translocated by the PROTEIN1PROTEIN2 binding peptides are derived from signal sequences , they may be released back into the cytosol and subsequently translocated by the PROTEIN complex and loaded onto PROTEIN molecules .
0	We have shown previously that Phe93 in the extracellular domain of the PROTEIN ( PROTEIN ) receptor ( PROTEIN1 ) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN2 ( EPO-binding protein or PROTEIN ) and no detectable binding to full-length mutant receptor expressed in COS cells .
0	We demonstrate that PROTEIN surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the transporter associated with antigen processing ( PROTEIN1PROTEIN2 with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the transporter associated with antigen processing ( PROTEIN ) and PROTEIN , and that PROTEIN expression is TAP-dependent and tapasin-dependent .
0	In the present study we evaluated tyrosine phosphorylation of PROTEIN and the interaction of the PROTEIN1/c-Cbl complex with signaling proteins upon activation of non-tyrosine ( PROTEIN2 ) and tyrosine kinase ( PROTEIN ) receptors leading to myeloid cell proliferation .
0	Expression of PROTEIN IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including PROTEIN , -2 , -4 , and -6 , while PROTEIN1 IIIb-expressing cells responded only to PROTEIN2 .
0	Here we report the crystal structure of human dimeric PROTEIN in complex with two high affinity PROTEIN1 extracellular domains ( PROTEIN2 ) .
1	Thus , Phe93 and Phe205 are important binding determinants for both PROTEIN and PROTEIN1 , even though these ligands share no sequence or structural homology , suggesting that these residues may represent a minimum epitope on the PROTEIN2 for productive ligand binding .
1	The splicing factor U2AF ( U2 snRNP auxiliary factor ) is a heterodimer with subunits of 65 and 35 kD ( PROTEIN1 and PROTEIN2 ) .
0	We demonstrate that PROTEIN surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN1 associates with the transporter associated with antigen processing ( PROTEIN ) and PROTEIN , and that PROTEIN2 expression is TAP-dependent and tapasin-dependent .
0	Discrete protein interactions with the Grb2/c-Cbl complex in SCF- and PROTEIN1PROTEIN2- and TPO-mediated myeloid cell proliferation .
0	Moreover we found that , upon PROTEIN1 stimulation , the Grb2/PROTEIN2 complex recruits PROTEIN , probably via PROTEIN .
1	This regulation results from a direct interaction between PROTEIN1 and PROTEIN2 .
0	Shared and unique determinants of the PROTEIN ( PROTEIN ) receptor are important for binding PROTEIN and PROTEIN1PROTEIN2 and PROTEIN mimetic peptide .
0	By using the growth factor dependent M-07e cell line , we found that both PROTEIN and PROTEIN1 ligands , namely : PROTEIN and PROTEIN , induce PROTEIN2 tyrosine phosphorylation .
1	PROTEIN1 , which is known to bind 14-3-3 proteins , has recently been shown to associate with PROTEIN2 and to stimulate its phosphatase activity .
0	In the present study we evaluated tyrosine phosphorylation of PROTEIN and the interaction of the Grb2/c-Cbl complex with signaling proteins upon activation of non-tyrosine ( PROTEIN1 ) and tyrosine kinase ( PROTEIN2 ) receptors leading to myeloid cell proliferation .
0	PROTEIN encodes a novel 21 kd protein that is found in PROTEIN1 , cyclin D1 , PROTEIN2 , and PROTEIN immunoprecipitates .
0	Remarkably , Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the PROTEIN1 bound to an PROTEIN2 ( PROTEIN ) , suggesting that Phe93 is also important for PROTEIN binding .
0	We demonstrate that PROTEIN surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of PROTEIN1 with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the transporter associated with antigen processing ( PROTEIN ) and PROTEIN , and that PROTEIN expression is PROTEIN2-dependent and tapasin-dependent .
0	These data demonstrate that the PROTEIN PROTEIN is the T-cell homologue of the cloned PROTEIN , and imply that the PROTEIN1PROTEIN2 , and imply that the PROTEIN and PROTEIN PROTEIN have different extracellular domains .
1	In vitro and in vivo experiments support the hypothesis that PROTEIN mediates the association of PROTEIN1 with PROTEIN2 .
0	The correlation between PROTEIN and MHC class I surface expression might be relevant to the function of HLA-E. Our results also show that , although these PROTEIN binding peptides are derived from signal sequences , they may be released back into the cytosol and subsequently translocated by the PROTEIN1PROTEIN2 .
0	By using the growth factor dependent M-07e cell line , we found that both PROTEIN1 and PROTEIN ligands , namely : PROTEIN and PROTEIN , induce PROTEIN2 tyrosine phosphorylation .
0	Two lines of evidence support the notion that PROTEIN and simian virus 40 T antigen have homologous Rb-binding properties : first , several mutated PROTEIN proteins that failed to bind to T also did not associate with PROTEIN1 ; and second , both T antigen and T peptide ( amino acids 101-118 ) were able to compete with PROTEIN2 for binding to PROTEIN .
0	PROTEIN recognizes one FGFR isoform known as the PROTEIN IIIb isoform or keratinocyte growth factor receptor ( PROTEIN1PROTEIN2 receptor ( PROTEIN ) , whereas PROTEIN binds well to PROTEIN , PROTEIN , and PROTEIN but interacts poorly with PROTEIN .
0	Two potentially oncogenic cyclins , cyclin A and cyclin D1 , share common properties of subunit configuration , tyrosine phosphorylation and physical association with the PROTEIN protein .Originally identified as a 'mitotic cyclin ' , PROTEIN1 exhibits properties of growth factor sensitivity , susceptibility to viral subversion and association with a tumor-suppressor protein , properties which are indicative of an PROTEIN2 ( PROTEIN ) as well as a candidate proto-oncogene .
1	By contrast stimulation with PROTEIN leads to the formation of a PROTEIN1 complex containing PROTEIN2 .
0	The correlation between PROTEIN and MHC class I surface expression might be relevant to the function of HLA-E. Our results also show that , although these PROTEIN1PROTEIN2 and MHC class I surface expression might be relevant to the function of HLA-E. Our results also show that , although these PROTEIN binding peptides are derived from signal sequences , they may be released back into the cytosol and subsequently translocated by the PROTEIN complex and loaded onto PROTEIN molecules .
1	Here we use simian virus 40 DNA replication in vitro to show than PROTEIN1 directly inhibits PROTEIN2-dependent DNA replication in the absence of a cyclin/CDK .
1	PROTEIN1 recognizes one FGFR isoform known as the PROTEIN IIIb isoform or PROTEIN2 ( PROTEIN ) , whereas PROTEIN binds well to PROTEIN , PROTEIN , and PROTEIN but interacts poorly with PROTEIN .
0	Expression of PROTEIN1 in stably transfected L6 cells conferred growth responses to several members of the FGF family including PROTEIN2 , -2 , -4 , and -6 , while PROTEIN IIIb-expressing cells responded only to PROTEIN .
0	Discrete protein interactions with the PROTEIN1/c-Cbl complex in PROTEIN2- and TPO-mediated myeloid cell proliferation .
0	Two potentially oncogenic cyclins , cyclin A and cyclin D1 , share common properties of subunit configuration , tyrosine phosphorylation and physical association with the PROTEIN protein .Originally identified as a 'mitotic cyclin ' , cyclin A exhibits properties of growth factor sensitivity , susceptibility to viral subversion and association with a tumor-suppressor protein , properties which are indicative of an S-phase-promoting factor ( PROTEIN1PROTEIN2 ( PROTEIN ) as well as a candidate proto-oncogene .
0	Expression of PROTEIN1 IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including PROTEIN , -2 , -4 , and -6 , while PROTEIN IIIb-expressing cells responded only to PROTEIN2 .
0	We demonstrate that PROTEIN surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the transporter associated with antigen processing ( PROTEIN1 ) and PROTEIN , and that PROTEIN2 expression is TAP-dependent and tapasin-dependent .
0	We have shown previously that Phe93 in the extracellular domain of the PROTEIN1 ( PROTEIN ) receptor ( PROTEIN ) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN2 or PROTEIN ) and no detectable binding to full-length mutant receptor expressed in COS cells .
0	The PROTEIN1/PROTEIN2 family of transcription factors is one of the main targets of cytokines and other agents that induce HIV-1 gene expression .
0	Discrete protein interactions with the Grb2/c-Cbl complex in SCF- and PROTEIN1PROTEIN2/c-Cbl complex in SCF- and TPO-mediated myeloid cell proliferation .
0	PROTEIN recognizes one FGFR isoform known as the PROTEIN IIIb isoform or PROTEIN1 ( PROTEIN ) , whereas PROTEIN binds well to PROTEIN , PROTEIN2 , and PROTEIN but interacts poorly with PROTEIN .
0	In vitro experiments showed that the stable Grb2/c-Cbl complex interacts , through the PROTEIN SH2 domain , with the PROTEIN1PROTEIN2 complex interacts , through the PROTEIN SH2 domain , with the SCF-activated PROTEIN .
0	PROTEIN is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN1 by cyclin A-Cdk2 , cyclin E-Cdk2 , cyclin D1-Cdk4 , and PROTEIN2-Cdk4 complexes .
0	Here , we describe the molecular cloning and characterization of PROTEIN1 , a distant relative of the PROTEIN2 group that is activated by dual phosphorylation at Thr and Tyr during the UV response .
0	Two lines of evidence support the notion that PROTEIN and simian virus 40 T antigen have homologous PROTEIN1-binding properties : first , several mutated PROTEIN proteins that failed to bind to T also did not associate with PROTEIN ; and second , both T antigen and T peptide ( amino acids 101-118 ) were able to compete with PROTEIN for binding to PROTEIN2 .
0	We have shown previously that Phe93 in the extracellular domain of the PROTEIN ( PROTEIN ) receptor ( PROTEIN ) is crucial for binding PROTEIN1.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN2-binding protein or PROTEIN ) and no detectable binding to full-length mutant receptor expressed in COS cells .
1	Shared and unique determinants of the PROTEIN1 are important for binding PROTEIN2 and PROTEIN mimetic peptide .
0	In vitro protein-protein interaction assays reveal that as observed with Drosophila PROTEIN1 , PROTEIN2 interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator viral protein 16 ( PROTEIN ) as well as with the general transcription factor PROTEIN .
0	PROTEIN recognizes one FGFR isoform known as the PROTEIN1 isoform or keratinocyte growth factor receptor ( PROTEIN ) , whereas PROTEIN binds well to PROTEIN , PROTEIN , and PROTEIN2 but interacts poorly with PROTEIN .
0	Immunoprecipitation experiments with human osteosarcoma cells and Ewing 's sarcoma cells demonstrated that cyclin D1 is associated with both PROTEIN1 and PROTEIN , and that PROTEIN2 immune complexes exhibit appreciable histone H1 kinase activity .
1	In vitro experiments showed that the stable Grb2/c-Cbl complex interacts , through the PROTEIN SH2 domain , with the PROTEIN1-activated PROTEIN2 .
0	In agreement , mAb to the previously cloned PROTEIN were found to stain unstimulated T cells that express only the PROTEIN PROTEIN1PROTEIN2 were found to stain unstimulated T cells that express only the PROTEIN PROTEIN but not T-cell clones that express predominantly the PROTEIN PROTEIN .
0	In vitro experiments showed that the stable Grb2/c-Cbl complex interacts , through the PROTEIN SH2 domain , with the SCF-activated PROTEIN1PROTEIN2/c-Cbl complex interacts , through the PROTEIN SH2 domain , with the SCF-activated PROTEIN .
0	In order to characterize the signaling pathway through which PROTEIN regulates cell growth , L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms , PROTEIN1 and PROTEIN IIIc , that result from alternative splicing of exon III of the PROTEIN2 gene encoding the ligand binding domain .
0	In vitro protein-protein interaction assays reveal that as observed with Drosophila PROTEIN , PROTEIN interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator PROTEIN1 ( PROTEIN2 ) as well as with the general transcription factor PROTEIN .
0	Moreover we found that , upon PROTEIN stimulation , the Grb2/c-Cbl complex recruits PROTEIN1PROTEIN2/c-Cbl complex recruits PROTEIN , probably via PROTEIN .
0	We have shown previously that Phe93 in the extracellular domain of the PROTEIN1 ( PROTEIN ) receptor ( PROTEIN ) is crucial for binding PROTEIN2.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( EPO-binding protein or PROTEIN ) and no detectable binding to full-length mutant receptor expressed in COS cells .
0	By contrast the PROTEIN exchanger factor ( PROTEIN ) was not detected in anti-PROTEIN1PROTEIN2 exchanger factor ( PROTEIN ) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and Grb2/c-Cbl are present in different complexes .
0	By contrast the PROTEIN exchanger factor ( PROTEIN ) was not detected in anti-c-Cbl immunoprecipitates suggesting that PROTEIN1/PROTEIN2 and Grb2/c-Cbl are present in different complexes .
0	After pervanadate treatment of MvLu cells , which inhibits cellular tyrosine phosphatase activity including PROTEIN1 , the cadherins associated with PROTEIN are now found in a tyrosine-phosphorylated form , indicating that the cadherins may be an endogenous substrate for PROTEIN2 .
0	We used alanine substitution of PROTEIN residues that contact PROTEIN in the crystal structure to investigate the function of these residues in both PROTEIN and PROTEIN1PROTEIN2 and PROTEIN binding .
0	PROTEIN is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN1 by PROTEIN2-Cdk2 , cyclin E-Cdk2 , cyclin D1-Cdk4 , and cyclin D2-Cdk4 complexes .
0	We have shown previously that Phe93 in the extracellular domain of the PROTEIN ( PROTEIN ) receptor ( PROTEIN ) is crucial for binding PROTEIN1.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN2 binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( EPO-binding protein or PROTEIN ) and no detectable binding to full-length mutant receptor expressed in COS cells .
0	Two lines of evidence support the notion that PROTEIN and simian virus 40 T antigen have homologous PROTEIN1-binding properties : first , several mutated PROTEIN proteins that failed to bind to T also did not associate with PROTEIN2 ; and second , both T antigen and T peptide ( amino acids 101-118 ) were able to compete with PROTEIN for binding to PROTEIN .
0	PROTEIN is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by cyclin A-PROTEIN1 , cyclin E-Cdk2 , cyclin D1-Cdk4 , and cyclin D2-PROTEIN2 complexes .
0	We demonstrate that PROTEIN surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN1PROTEIN2 .
0	Expression of PROTEIN1 IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including PROTEIN , -2 , -4 , and -6 , while PROTEIN2-expressing cells responded only to PROTEIN .
0	Expression of PROTEIN IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including PROTEIN1 , -2 , -4 , and -6 , while PROTEIN IIIb-expressing cells responded only to PROTEIN2 .
0	We demonstrate that PROTEIN surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN1 associates with the transporter associated with antigen processing ( PROTEIN ) and PROTEIN , and that PROTEIN expression is PROTEIN2-dependent and tapasin-dependent .
0	Transcription factor PROTEIN consists of TATA binding protein ( PROTEIN1 ) and at least eight PROTEIN2-associated factors ( TAFs ) .
0	In agreement , mAb to the previously cloned PROTEIN were found to stain unstimulated T cells that express only the PROTEIN PROTEIN1 but not T-cell clones that express predominantly the PROTEIN2 PROTEIN .
0	PROTEIN is a ligand for the PROTEIN1PROTEIN2 receptor protein-tyrosine kinase .
1	PROTEIN recognizes one FGFR isoform known as the PROTEIN IIIb isoform or keratinocyte growth factor receptor ( PROTEIN ) , whereas PROTEIN1 binds well to PROTEIN , PROTEIN2 , and PROTEIN but interacts poorly with PROTEIN .
0	Two potentially oncogenic cyclins , PROTEIN1 and PROTEIN2 , share common properties of subunit configuration , tyrosine phosphorylation and physical association with the PROTEIN protein .Originally identified as a 'mitotic cyclin ' , cyclin A exhibits properties of growth factor sensitivity , susceptibility to viral subversion and association with a tumor-suppressor protein , properties which are indicative of an S-phase-promoting factor ( PROTEIN ) as well as a candidate proto-oncogene .
0	PROTEIN recognizes one FGFR isoform known as the PROTEIN IIIb isoform or keratinocyte growth factor receptor ( PROTEIN1 ) , whereas PROTEIN binds well to PROTEIN2 , PROTEIN , and PROTEIN but interacts poorly with PROTEIN .
1	PROTEIN is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN1-PROTEIN2 , cyclin E-Cdk2 , cyclin D1-Cdk4 , and cyclin D2-Cdk4 complexes .
0	Replacement of this loop with the homologous loop from PROTEIN dramatically reduced both the affinity of PROTEIN for PROTEIN1PROTEIN2 dramatically reduced both the affinity of PROTEIN for PROTEIN and its biological potency but did not result in the ability to bind PROTEIN .
0	PROTEIN is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by cyclin A-PROTEIN1 , cyclin E-Cdk2 , cyclin D1-PROTEIN2 , and cyclin D2-Cdk4 complexes .
0	By contrast the PROTEIN exchanger factor ( PROTEIN ) was not detected in anti-c-Cbl immunoprecipitates suggesting that PROTEIN1PROTEIN2 exchanger factor ( PROTEIN ) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and Grb2/c-Cbl are present in different complexes .
0	The correlation between PROTEIN and MHC class I surface expression might be relevant to the function of HLA-E. Our results also show that , although these PROTEIN binding peptides are derived from signal sequences , they may be released back into the cytosol and subsequently translocated by the PROTEIN complex and loaded onto PROTEIN1PROTEIN2 binding peptides are derived from signal sequences , they may be released back into the cytosol and subsequently translocated by the PROTEIN complex and loaded onto PROTEIN molecules .
0	Functional studies in Jurkat T lymphocytic cells point to the importance of both the PROTEIN and PROTEIN1PROTEIN2 and PROTEIN binding sites in PROTEIN mediated repression of HIV-1 promoter , in vivo .
1	The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ( PROTEIN , FADD/PROTEIN1 , RIP , FLICE/MACH , and TRAFs ) associated with both of the PROTEIN2 and PROTEIN forms of the TNF receptor and with other members of the TNF receptor superfamily .
0	PROTEIN is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN1-Cdk2 , cyclin E-Cdk2 , cyclin D1-PROTEIN2 , and cyclin D2-Cdk4 complexes .
0	In the present study we evaluated tyrosine phosphorylation of PROTEIN1 and the interaction of the Grb2/PROTEIN2 complex with signaling proteins upon activation of non-tyrosine ( PROTEIN ) and tyrosine kinase ( PROTEIN ) receptors leading to myeloid cell proliferation .
0	We demonstrate that PROTEIN surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the transporter associated with antigen processing ( PROTEIN1PROTEIN2 .
0	PROTEIN recognizes one FGFR isoform known as the PROTEIN IIIb isoform or PROTEIN1 receptor ( PROTEIN ) , whereas PROTEIN binds well to PROTEIN , PROTEIN2 , and PROTEIN but interacts poorly with PROTEIN .
0	By contrast the PROTEIN exchanger factor ( PROTEIN ) was not detected in anti-c-Cbl immunoprecipitates suggesting that PROTEIN1PROTEIN2 ) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and Grb2/c-Cbl are present in different complexes .
0	By contrast the PROTEIN exchanger factor ( PROTEIN ) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and Grb2/PROTEIN1PROTEIN2/Sos1 and Grb2/c-Cbl are present in different complexes .
0	Gel retardation/immunoblot analysis using purified PROTEIN1 and PROTEIN2 homodimers reveals the presence of complexes containing both proteins .
1	The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ( PROTEIN , FADD/MORT , RIP , PROTEIN1/MACH , and TRAFs ) associated with both of the PROTEIN2 and PROTEIN forms of the TNF receptor and with other members of the TNF receptor superfamily .
0	PROTEIN is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN1 by cyclin A-Cdk2 , cyclin E-Cdk2 , cyclin D1-PROTEIN2 , and cyclin D2-Cdk4 complexes .
0	The correlation between PROTEIN and MHC class I surface expression might be relevant to the function of HLA-E. Our results also show that , although these PROTEIN binding peptides are derived from signal sequences , they may be released back into the cytosol and subsequently translocated by the PROTEIN complex and loaded onto PROTEIN1PROTEIN2 complex and loaded onto PROTEIN molecules .
1	We used alanine substitution of PROTEIN1 residues that contact PROTEIN2 in the crystal structure to investigate the function of these residues in both PROTEIN and PROTEIN binding .
0	A protein ligand for the PROTEIN receptor protein-tyrosine kinase has been isolated by using the extracellular domain ( PROTEIN1PROTEIN2 receptor protein-tyrosine kinase has been isolated by using the extracellular domain ( ECK-X ) of the receptor as an affinity reagent .
1	We have shown previously that Phe93 in the extracellular domain of the PROTEIN ( PROTEIN1 ) receptor ( PROTEIN2 ) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( EPO-binding protein or PROTEIN ) and no detectable binding to full-length mutant receptor expressed in COS cells .
0	Remarkably , Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the PROTEIN1 bound to an PROTEIN2-mimetic peptide ( PROTEIN ) , suggesting that Phe93 is also important for PROTEIN binding .
0	We have shown previously that Phe93 in the extracellular domain of the PROTEIN1 ( PROTEIN ) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN2-binding protein or PROTEIN ) and no detectable binding to full-length mutant receptor expressed in COS cells .
0	Immunoprecipitation experiments with human osteosarcoma cells and Ewing 's sarcoma cells demonstrated that cyclin D1 is associated with both PROTEIN and PROTEIN1 , and that PROTEIN2 immune complexes exhibit appreciable histone H1 kinase activity .
0	Bone morphogenetic proteins ( BMPs ) belong to the large transforming growth factor-beta ( PROTEIN1PROTEIN2 ( PROTEIN ) superfamily of multifunctional cytokines .
0	Two lines of evidence support the notion that PROTEIN and simian virus 40 T antigen have homologous Rb-binding properties : first , several mutated PROTEIN1 proteins that failed to bind to T also did not associate with PROTEIN ; and second , both T antigen and T peptide ( amino acids 101-118 ) were able to compete with PROTEIN for binding to PROTEIN2 .
0	PROTEIN1 and 80K-H.PROTEIN2 .
0	We have shown previously that Phe93 in the extracellular domain of the PROTEIN ( PROTEIN ) receptor ( PROTEIN1 ) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN2-binding protein or PROTEIN ) and no detectable binding to full-length mutant receptor expressed in COS cells .
1	In vitro protein-protein interaction assays reveal that as observed with Drosophila PROTEIN , PROTEIN1 interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator viral protein 16 ( PROTEIN ) as well as with the general transcription factor PROTEIN2 .
0	Shared and unique determinants of the PROTEIN ( PROTEIN ) receptor are important for binding PROTEIN and PROTEIN1PROTEIN2 mimetic peptide .
0	PROTEIN recognizes one FGFR isoform known as the PROTEIN IIIb isoform or keratinocyte growth factor receptor ( PROTEIN ) , whereas PROTEIN binds well to PROTEIN , PROTEIN , and PROTEIN1 but interacts poorly with PROTEIN2 .
0	We have shown previously that Phe93 in the extracellular domain of the PROTEIN1PROTEIN2 ( PROTEIN ) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( EPO-binding protein or PROTEIN ) and no detectable binding to full-length mutant receptor expressed in COS cells .
0	By contrast the PROTEIN exchanger factor ( PROTEIN ) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and PROTEIN1PROTEIN2 exchanger factor ( PROTEIN ) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and Grb2/c-Cbl are present in different complexes .
0	The correlation between PROTEIN and MHC class I surface expression might be relevant to the function of HLA-E. Our results also show that , although these PROTEIN binding peptides are derived from signal sequences , they may be released back into the cytosol and subsequently translocated by the PROTEIN complex and loaded onto PROTEIN1PROTEIN2 and MHC class I surface expression might be relevant to the function of HLA-E. Our results also show that , although these PROTEIN binding peptides are derived from signal sequences , they may be released back into the cytosol and subsequently translocated by the PROTEIN complex and loaded onto PROTEIN molecules .
0	Hemopoietic cell proliferation is mediated by non-tyrosine and tyrosine kinases that signal via uncommon and common sets of downstream effector molecules including the Grb2/PROTEIN1PROTEIN2/c-Cbl .
0	Moreover , a partial recombinant PROTEIN1 complex containing PROTEIN was capable of mediating in vitro transcriptional activation by the PROTEIN2 activation domain .
0	We find that PROTEIN1 is the human homologue of Drosophila PROTEIN2 .
0	Subsequently , supernatants from selected cell lines were fractionated directly by receptor affinity chromatography , resulting in the single-step purification of PROTEIN1 , a protein previously identified as the product of an early response gene induced by PROTEIN2 .
0	The reciprocal loop replacement mutant ( FGF2-L4/7 ) retained PROTEIN like affinity for PROTEIN and for PROTEIN1PROTEIN2 and for PROTEIN .
0	Replacement of this loop with the homologous loop from PROTEIN dramatically reduced both the affinity of PROTEIN1PROTEIN2 dramatically reduced both the affinity of PROTEIN for PROTEIN and its biological potency but did not result in the ability to bind PROTEIN .
0	PROTEIN recognizes one FGFR isoform known as the PROTEIN IIIb isoform or keratinocyte growth factor receptor ( PROTEIN ) , whereas PROTEIN binds well to PROTEIN1PROTEIN2 recognizes one FGFR isoform known as the PROTEIN IIIb isoform or keratinocyte growth factor receptor ( PROTEIN ) , whereas PROTEIN binds well to PROTEIN , PROTEIN , and PROTEIN but interacts poorly with PROTEIN .
0	PROTEIN complex following PROTEIN1PROTEIN2 complex following PROTEIN phosphorylation .
0	In order to characterize the signaling pathway through which PROTEIN1 regulates cell growth , L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms , PROTEIN2 IIIb and PROTEIN IIIc , that result from alternative splicing of exon III of the PROTEIN gene encoding the ligand binding domain .
0	Two lines of evidence support the notion that PROTEIN and simian virus 40 T antigen have homologous Rb-binding properties : first , several mutated PROTEIN proteins that failed to bind to T also did not associate with PROTEIN1 ; and second , both T antigen and T peptide ( amino acids 101-118 ) were able to compete with PROTEIN for binding to PROTEIN2 .
0	These data demonstrate that the PROTEIN PROTEIN is the T-cell homologue of the cloned PROTEIN , and imply that the PROTEIN and PROTEIN1PROTEIN2 and PROTEIN PROTEIN have different extracellular domains .
1	The interaction between PROTEIN ( PROTEIN ) and PROTEIN1 receptor ( PROTEIN2 ) is the initial and most specific step in the PROTEIN signaling pathway .
0	Shared and unique determinants of the PROTEIN1PROTEIN2 are important for binding PROTEIN and PROTEIN mimetic peptide .
0	PROTEIN recognizes one FGFR isoform known as the PROTEIN IIIb isoform or keratinocyte growth factor receptor ( PROTEIN ) , whereas PROTEIN binds well to PROTEIN , PROTEIN1 , and PROTEIN2 but interacts poorly with PROTEIN .
0	Deglycosylation studies showed that the PROTEIN and PROTEIN PROTEIN1PROTEIN2 PROTEIN are not simply differently glycosylated isoforms of a single receptor .
0	PROTEIN is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN1-Cdk2 , cyclin E-Cdk2 , cyclin D1-Cdk4 , and cyclin D2-PROTEIN2 complexes .
1	The sequences that confer on PROTEIN1 its specific binding to PROTEIN2 have not been identified .
0	Two potentially oncogenic cyclins , cyclin A and cyclin D1 , share common properties of subunit configuration , tyrosine phosphorylation and physical association with the PROTEIN1 protein .Originally identified as a 'mitotic cyclin ' , cyclin A exhibits properties of growth factor sensitivity , susceptibility to viral subversion and association with a tumor-suppressor protein , properties which are indicative of an PROTEIN2 ( PROTEIN ) as well as a candidate proto-oncogene .
0	Shared and unique determinants of the PROTEIN ( PROTEIN ) receptor are important for binding PROTEIN and PROTEIN1PROTEIN2 ( PROTEIN ) receptor are important for binding PROTEIN and PROTEIN mimetic peptide .
0	PROTEIN recognizes one FGFR isoform known as the PROTEIN IIIb isoform or keratinocyte growth factor receptor ( PROTEIN ) , whereas PROTEIN binds well to PROTEIN , PROTEIN1 , and PROTEIN but interacts poorly with PROTEIN2 .
0	We demonstrate that PROTEIN surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the transporter associated with antigen processing ( PROTEIN ) and PROTEIN , and that PROTEIN1 expression is PROTEIN2-dependent and tapasin-dependent .
1	We used alanine substitution of PROTEIN1 residues that contact PROTEIN in the crystal structure to investigate the function of these residues in both PROTEIN2 and PROTEIN binding .
0	PROTEIN encodes a novel 21 kd protein that is found in cyclin A , cyclin D1 , cyclin E , and PROTEIN1PROTEIN2 , cyclin E , and PROTEIN immunoprecipitates .
1	The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ( PROTEIN , FADD/MORT , RIP , PROTEIN1/MACH , and TRAFs ) associated with both of the PROTEIN and PROTEIN2 forms of the TNF receptor and with other members of the TNF receptor superfamily .
1	This last observation was confirmed by affinity chromatography and immunoprecipitation , which demonstrated an interaction between PROTEIN1 and PROTEIN2 .
0	By contrast the PROTEIN exchanger factor ( PROTEIN ) was not detected in anti-PROTEIN1PROTEIN2 ) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and Grb2/c-Cbl are present in different complexes .
0	Moreover we found that , upon PROTEIN stimulation , the Grb2/c-Cbl complex recruits PROTEIN , probably via PROTEIN1PROTEIN2 stimulation , the Grb2/c-Cbl complex recruits PROTEIN , probably via PROTEIN .
0	Cotransfection experiments indicate that PROTEIN and PROTEIN1PROTEIN2 and SV40 T antigen function in a mutually antagonistic manner to control cell cycle progression .
1	The interaction between PROTEIN1 ( PROTEIN ) and PROTEIN receptor ( PROTEIN2 ) is the initial and most specific step in the PROTEIN signaling pathway .
0	By contrast the PROTEIN exchanger factor ( PROTEIN ) was not detected in anti-c-Cbl immunoprecipitates suggesting that PROTEIN1PROTEIN2 immunoprecipitates suggesting that Grb2/Sos1 and Grb2/c-Cbl are present in different complexes .
0	We demonstrate that PROTEIN1 surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to PROTEIN2 .
0	Moreover , a partial recombinant PROTEIN complex containing PROTEIN1 was capable of mediating in vitro transcriptional activation by the PROTEIN2 activation domain .
0	In agreement , mAb to the previously cloned PROTEIN1 were found to stain unstimulated T cells that express only the PROTEIN PROTEIN but not T-cell clones that express predominantly the PROTEIN PROTEIN2 .
0	In addition , 80K-H. PROTEIN1PROTEIN2 .
0	PROTEIN ; these two complexes may alternatively link PROTEIN to PROTEIN1PROTEIN2 ; these two complexes may alternatively link PROTEIN to mitogen-activated protein kinase .
0	We demonstrate that PROTEIN1 surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN2 associates with the transporter associated with antigen processing ( PROTEIN ) and PROTEIN , and that PROTEIN expression is TAP-dependent and tapasin-dependent .
0	Finally , activated PROTEIN1 was also found to result in phosphorylation of phospholipase C-gamma but reduced phosphorylation of PROTEIN2 .
0	PROTEIN recognizes one FGFR isoform known as the PROTEIN IIIb isoform or keratinocyte growth factor receptor ( PROTEIN1PROTEIN2 ( PROTEIN ) , whereas PROTEIN binds well to PROTEIN , PROTEIN , and PROTEIN but interacts poorly with PROTEIN .
0	In summary , PROTEIN1 signaling pathway utilizes two GRB2-containing complexes ; PROTEIN2 .
0	Two lines of evidence support the notion that PROTEIN and simian virus 40 T antigen have homologous Rb-binding properties : first , several mutated PROTEIN1 proteins that failed to bind to T also did not associate with PROTEIN2 ; and second , both T antigen and T peptide ( amino acids 101-118 ) were able to compete with PROTEIN for binding to PROTEIN .
0	PROTEIN is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN1-Cdk2 , cyclin E-Cdk2 , cyclin D1-Cdk4 , and PROTEIN2-Cdk4 complexes .
1	The PROTEIN1 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PROTEIN2 .
1	In vitro experiments showed that the stable PROTEIN1/PROTEIN2 complex interacts , through the PROTEIN SH2 domain , with the SCF-activated PROTEIN .
0	We have shown previously that Phe93 in the extracellular domain of the PROTEIN ( PROTEIN ) receptor ( PROTEIN ) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN1 binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN2-binding protein or PROTEIN ) and no detectable binding to full-length mutant receptor expressed in COS cells .
0	Moreover we found that , upon PROTEIN stimulation , the Grb2/c-Cbl complex recruits PROTEIN , probably via PROTEIN1PROTEIN2/c-Cbl complex recruits PROTEIN , probably via PROTEIN .
1	In normal human cells , but not in many tumour cells , PROTEIN1 exists in a quaternary complex with a cyclin , a CDK , and the proliferating-cell nuclear antigen ( PROTEIN2 ) .
1	In vitro protein-protein interaction assays reveal that as observed with Drosophila PROTEIN , PROTEIN1 interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator viral protein 16 ( PROTEIN2 ) as well as with the general transcription factor PROTEIN .
0	PROTEIN recognizes one FGFR isoform known as the PROTEIN IIIb isoform or keratinocyte growth factor receptor ( PROTEIN1 ) , whereas PROTEIN binds well to PROTEIN , PROTEIN , and PROTEIN but interacts poorly with PROTEIN2 .
0	Here we report the crystal structure of human dimeric PROTEIN in complex with two high affinity PROTEIN1PROTEIN2s ( PROTEIN ) .
1	PROTEIN is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by cyclin A-Cdk2 , cyclin E-Cdk2 , cyclin D1-Cdk4 , and PROTEIN1-PROTEIN2 complexes .
0	PROTEIN recognizes one FGFR isoform known as the PROTEIN IIIb isoform or keratinocyte growth factor receptor ( PROTEIN1 ) , whereas PROTEIN binds well to PROTEIN , PROTEIN2 , and PROTEIN but interacts poorly with PROTEIN .
0	14-3-3 protein , however , has no effect on the PROTEIN1-kinase activity of PROTEIN2 .
0	PROTEIN recognizes one FGFR isoform known as the PROTEIN IIIb isoform or keratinocyte growth factor receptor ( PROTEIN1PROTEIN2 isoform or keratinocyte growth factor receptor ( PROTEIN ) , whereas PROTEIN binds well to PROTEIN , PROTEIN , and PROTEIN but interacts poorly with PROTEIN .
0	Here we report the crystal structure of human dimeric PROTEIN1 in complex with two high affinity PROTEIN2 extracellular domains ( PROTEIN ) .
0	Here , we demonstrate that PROTEIN may regulate the activity of the HIV-1 long terminal repeat through its ability to bind sequences in the PROTEIN enhancer region and to interact with the PROTEIN1PROTEIN2 enhancer region and to interact with the PROTEIN subunit , PROTEIN .
0	We demonstrate that PROTEIN1 surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the transporter associated with antigen processing ( PROTEIN2 ) and PROTEIN , and that PROTEIN expression is TAP-dependent and tapasin-dependent .
0	In order to characterize the signaling pathway through which PROTEIN1 regulates cell growth , L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms , PROTEIN IIIb and PROTEIN IIIc , that result from alternative splicing of exon III of the PROTEIN2 gene encoding the ligand binding domain .
0	In vitro experiments showed that the stable Grb2/c-Cbl complex interacts , through the PROTEIN1PROTEIN2 complex interacts , through the PROTEIN SH2 domain , with the SCF-activated PROTEIN .
1	The interaction between PROTEIN ( PROTEIN1 ) and PROTEIN2 ( PROTEIN ) is the initial and most specific step in the PROTEIN signaling pathway .
0	Shared and unique determinants of the PROTEIN ( PROTEIN ) receptor are important for binding PROTEIN1PROTEIN2 ( PROTEIN ) receptor are important for binding PROTEIN and PROTEIN mimetic peptide .
0	The correlation between PROTEIN1 and MHC class I surface expression might be relevant to the function of PROTEIN2 .
0	The reciprocal loop replacement mutant ( FGF2-L4/7 ) retained PROTEIN like affinity for PROTEIN1PROTEIN2-L4/7 ) retained PROTEIN like affinity for PROTEIN and for PROTEIN .
0	In order to characterize the signaling pathway through which PROTEIN regulates cell growth , L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms , PROTEIN1 IIIb and PROTEIN IIIc , that result from alternative splicing of exon III of the PROTEIN2 gene encoding the ligand binding domain .
0	Our results indicate that Phe93 and Phe205 are important for both PROTEIN and PROTEIN binding , Met150 is not important for PROTEIN binding but is critical for PROTEIN1PROTEIN2 binding , Met150 is not important for PROTEIN binding but is critical for PROTEIN binding , and Thr151 is not important for binding either ligand .
0	We demonstrate that PROTEIN surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the PROTEIN1 ( PROTEIN ) and PROTEIN , and that PROTEIN expression is PROTEIN2-dependent and tapasin-dependent .
0	In this article , we demonstrate that PROTEIN1 associates with a complex containing PROTEIN2- and PROTEIN in mink lung ( MvLu ) cells , and in rat heart , lung , and brain tissues .
0	We demonstrate that PROTEIN surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the transporter associated with antigen processing ( PROTEIN ) and PROTEIN1 , and that PROTEIN expression is PROTEIN2-dependent and tapasin-dependent .
0	Two potentially oncogenic cyclins , cyclin A and PROTEIN1 , share common properties of subunit configuration , tyrosine phosphorylation and physical association with the PROTEIN protein .Originally identified as a 'mitotic cyclin ' , cyclin A exhibits properties of growth factor sensitivity , susceptibility to viral subversion and association with a tumor-suppressor protein , properties which are indicative of an PROTEIN2 ( PROTEIN ) as well as a candidate proto-oncogene .
0	We demonstrate that PROTEIN1 surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of PROTEIN2 with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the transporter associated with antigen processing ( PROTEIN ) and PROTEIN , and that PROTEIN expression is TAP-dependent and tapasin-dependent .
0	Two lines of evidence support the notion that PROTEIN and PROTEIN1 have homologous Rb-binding properties : first , several mutated PROTEIN proteins that failed to bind to T also did not associate with PROTEIN ; and second , both T antigen and T peptide ( amino acids 101-118 ) were able to compete with PROTEIN2 for binding to PROTEIN .
0	PROTEIN : a protein kinase stimulated by UV light and PROTEIN that binds and phosphorylates the PROTEIN1PROTEIN2 that binds and phosphorylates the PROTEIN activation domain .
0	PROTEIN1 is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by cyclin A-Cdk2 , PROTEIN2-Cdk2 , cyclin D1-Cdk4 , and cyclin D2-Cdk4 complexes .
0	By using the growth factor dependent M-07e cell line , we found that both PROTEIN1 and PROTEIN2 ligands , namely : PROTEIN and PROTEIN , induce PROTEIN tyrosine phosphorylation .
0	PROTEIN1 is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by cyclin A-Cdk2 , cyclin E-Cdk2 , cyclin D1-Cdk4 , and PROTEIN2-Cdk4 complexes .
0	PROTEIN recognizes one FGFR isoform known as the PROTEIN IIIb isoform or keratinocyte growth factor receptor ( PROTEIN ) , whereas PROTEIN binds well to PROTEIN1PROTEIN2 isoform or keratinocyte growth factor receptor ( PROTEIN ) , whereas PROTEIN binds well to PROTEIN , PROTEIN , and PROTEIN but interacts poorly with PROTEIN .
1	We have shown previously that Phe93 in the extracellular domain of the PROTEIN ( PROTEIN ) receptor ( PROTEIN ) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN1 binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN2 or PROTEIN ) and no detectable binding to full-length mutant receptor expressed in COS cells .
0	Remarkably , Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the PROTEIN bound to an EPO-mimetic peptide ( PROTEIN1PROTEIN2-mimetic peptide ( PROTEIN ) , suggesting that Phe93 is also important for PROTEIN binding .
0	The correlation between PROTEIN and MHC class I surface expression might be relevant to the function of HLA-E. Our results also show that , although these PROTEIN binding peptides are derived from signal sequences , they may be released back into the cytosol and subsequently translocated by the PROTEIN complex and loaded onto PROTEIN1PROTEIN2 .
0	Transcription factor PROTEIN1 consists of PROTEIN2 ( PROTEIN ) and at least eight TBP-associated factors ( TAFs ) .
0	PROTEIN recognizes one FGFR isoform known as the PROTEIN IIIb isoform or PROTEIN1 receptor ( PROTEIN ) , whereas PROTEIN binds well to PROTEIN2 , PROTEIN , and PROTEIN but interacts poorly with PROTEIN .
0	We report here that recombinant PROTEIN induces autophosphorylation of PROTEIN1 in intact cells , consistent with PROTEIN being an authentic ligand for PROTEIN2 .
0	The reciprocal loop replacement mutant ( FGF2-L4/7 ) retained PROTEIN1PROTEIN2-L4/7 ) retained PROTEIN like affinity for PROTEIN and for PROTEIN .
1	The interaction between PROTEIN1 ( PROTEIN ) and PROTEIN2 ( PROTEIN ) is the initial and most specific step in the PROTEIN signaling pathway .
0	Expression of PROTEIN IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including PROTEIN1 , -2 , -4 , and -6 , while PROTEIN2 IIIb-expressing cells responded only to PROTEIN .
1	We have shown previously that Phe93 in the extracellular domain of the PROTEIN1 ( PROTEIN ) receptor ( PROTEIN2 ) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( EPO-binding protein or PROTEIN ) and no detectable binding to full-length mutant receptor expressed in COS cells .
0	PROTEIN is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by cyclin A-PROTEIN1 , cyclin E-Cdk2 , cyclin D1-Cdk4 , and PROTEIN2-Cdk4 complexes .
0	We have shown previously that Phe93 in the extracellular domain of the PROTEIN ( PROTEIN ) receptor ( PROTEIN1 ) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN2 binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( EPO-binding protein or PROTEIN ) and no detectable binding to full-length mutant receptor expressed in COS cells .
0	Two potentially oncogenic cyclins , cyclin A and cyclin D1 , share common properties of subunit configuration , tyrosine phosphorylation and physical association with the PROTEIN protein .Originally identified as a 'mitotic cyclin ' , cyclin A exhibits properties of growth factor sensitivity , susceptibility to viral subversion and association with a tumor-suppressor protein , properties which are indicative of an S-phase-promoting factor ( PROTEIN1PROTEIN2 exhibits properties of growth factor sensitivity , susceptibility to viral subversion and association with a tumor-suppressor protein , properties which are indicative of an S-phase-promoting factor ( PROTEIN ) as well as a candidate proto-oncogene .
0	The interaction between PROTEIN1 ( PROTEIN ) and PROTEIN receptor ( PROTEIN ) is the initial and most specific step in the PROTEIN2 signaling pathway .
0	We demonstrate that PROTEIN surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the PROTEIN1PROTEIN2 with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the transporter associated with antigen processing ( PROTEIN ) and PROTEIN , and that PROTEIN expression is TAP-dependent and tapasin-dependent .
0	We have shown previously that Phe93 in the extracellular domain of the PROTEIN ( PROTEIN ) receptor ( PROTEIN ) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN1-binding protein or PROTEIN2 ) and no detectable binding to full-length mutant receptor expressed in COS cells .
0	The interaction between PROTEIN ( PROTEIN ) and PROTEIN1 ( PROTEIN ) is the initial and most specific step in the PROTEIN2 signaling pathway .
0	Immunoprecipitation experiments with human osteosarcoma cells and Ewing 's sarcoma cells demonstrated that PROTEIN1 is associated with both PROTEIN and PROTEIN , and that PROTEIN2 immune complexes exhibit appreciable histone H1 kinase activity .
0	We demonstrate that PROTEIN surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the transporter associated with antigen processing ( PROTEIN ) and PROTEIN1 , and that PROTEIN2 expression is TAP-dependent and tapasin-dependent .
0	In the present study we evaluated tyrosine phosphorylation of PROTEIN and the interaction of the Grb2/PROTEIN1 complex with signaling proteins upon activation of non-tyrosine ( PROTEIN ) and tyrosine kinase ( PROTEIN2 ) receptors leading to myeloid cell proliferation .
0	We have shown previously that Phe93 in the extracellular domain of the PROTEIN ( PROTEIN ) receptor ( PROTEIN ) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN1 ( PROTEIN2-binding protein or PROTEIN ) and no detectable binding to full-length mutant receptor expressed in COS cells .
0	Deglycosylation studies showed that the PROTEIN and PROTEIN PROTEIN1PROTEIN2 and PROTEIN PROTEIN are not simply differently glycosylated isoforms of a single receptor .
1	Replacement of this loop with the homologous loop from PROTEIN dramatically reduced both the affinity of PROTEIN1 for PROTEIN2 and its biological potency but did not result in the ability to bind PROTEIN .
0	The interaction between PROTEIN1 ( PROTEIN2 ) and PROTEIN receptor ( PROTEIN ) is the initial and most specific step in the PROTEIN signaling pathway .
0	PROTEIN complex via the adapter protein PROTEIN1PROTEIN2 complex via the adapter protein PROTEIN .
0	PROTEIN1 encodes a novel 21 kd protein that is found in cyclin A , PROTEIN2 , cyclin E , and PROTEIN immunoprecipitates .
0	Our results indicate that Phe93 and Phe205 are important for both PROTEIN and PROTEIN binding , Met150 is not important for PROTEIN1PROTEIN2 and PROTEIN binding , Met150 is not important for PROTEIN binding but is critical for PROTEIN binding , and Thr151 is not important for binding either ligand .
1	In the present study we evaluated tyrosine phosphorylation of PROTEIN and the interaction of the PROTEIN1/PROTEIN2 complex with signaling proteins upon activation of non-tyrosine ( PROTEIN ) and tyrosine kinase ( PROTEIN ) receptors leading to myeloid cell proliferation .
0	PROTEIN recognizes one FGFR isoform known as the PROTEIN IIIb isoform or keratinocyte growth factor receptor ( PROTEIN ) , whereas PROTEIN1PROTEIN2 ( PROTEIN ) , whereas PROTEIN binds well to PROTEIN , PROTEIN , and PROTEIN but interacts poorly with PROTEIN .
0	PROTEIN is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by cyclin A-Cdk2 , cyclin E-Cdk2 , PROTEIN1-Cdk4 , and PROTEIN2-Cdk4 complexes .
1	We have shown previously that Phe93 in the extracellular domain of the PROTEIN ( PROTEIN ) receptor ( PROTEIN ) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN1 binding to the Escherichia coli-expressed extracellular domain of the PROTEIN2 ( EPO-binding protein or PROTEIN ) and no detectable binding to full-length mutant receptor expressed in COS cells .
1	The reciprocal loop replacement mutant ( FGF2-L4/7 ) retained PROTEIN1 like affinity for PROTEIN2 and for PROTEIN .
0	PROTEIN recognizes one FGFR isoform known as the PROTEIN IIIb isoform or PROTEIN1PROTEIN2 isoform or keratinocyte growth factor receptor ( PROTEIN ) , whereas PROTEIN binds well to PROTEIN , PROTEIN , and PROTEIN but interacts poorly with PROTEIN .
0	By contrast stimulation with PROTEIN leads to the formation of a PROTEIN complex containing PROTEIN1PROTEIN2 leads to the formation of a PROTEIN complex containing PROTEIN .
0	PROTEIN recognizes one FGFR isoform known as the PROTEIN IIIb isoform or keratinocyte growth factor receptor ( PROTEIN ) , whereas PROTEIN1PROTEIN2 receptor ( PROTEIN ) , whereas PROTEIN binds well to PROTEIN , PROTEIN , and PROTEIN but interacts poorly with PROTEIN .
0	Remarkably , Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the PROTEIN bound to an EPO-mimetic peptide ( PROTEIN ) , suggesting that Phe93 is also important for PROTEIN1PROTEIN2 ) , suggesting that Phe93 is also important for PROTEIN binding .
0	In order to characterize the signaling pathway through which PROTEIN regulates cell growth , L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms , PROTEIN IIIb and PROTEIN1PROTEIN2 regulates cell growth , L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms , PROTEIN IIIb and PROTEIN IIIc , that result from alternative splicing of exon III of the PROTEIN gene encoding the ligand binding domain .
1	By contrast the PROTEIN1 exchanger factor ( PROTEIN2 ) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and Grb2/c-Cbl are present in different complexes .
0	Transcription factor PROTEIN consists of TATA binding protein ( PROTEIN1PROTEIN2 consists of TATA binding protein ( PROTEIN ) and at least eight TBP-associated factors ( TAFs ) .
0	We have shown previously that Phe93 in the extracellular domain of the PROTEIN ( PROTEIN1 ) receptor ( PROTEIN ) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN2-binding protein or PROTEIN ) and no detectable binding to full-length mutant receptor expressed in COS cells .
0	Here we report the cloning , expression , and biochemical characterization of the 32-kDa subunit of human ( h ) PROTEIN , termed PROTEIN1PROTEIN2 , termed PROTEIN .
0	We have shown previously that Phe93 in the extracellular domain of the PROTEIN1 ( PROTEIN ) receptor ( PROTEIN ) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN2 ( EPO-binding protein or PROTEIN ) and no detectable binding to full-length mutant receptor expressed in COS cells .
1	We studied the capacity of these mutants to form an PROTEIN1/PROTEIN2 complex and their ability to transduce the signal .
0	The interaction between PROTEIN ( PROTEIN ) and PROTEIN1 ( PROTEIN2 ) is the initial and most specific step in the PROTEIN signaling pathway .
0	PROTEIN recognizes one FGFR isoform known as the PROTEIN IIIb isoform or PROTEIN1PROTEIN2 ( PROTEIN ) , whereas PROTEIN binds well to PROTEIN , PROTEIN , and PROTEIN but interacts poorly with PROTEIN .
1	PROTEIN recognizes one FGFR isoform known as the PROTEIN IIIb isoform or keratinocyte growth factor receptor ( PROTEIN ) , whereas PROTEIN1 binds well to PROTEIN , PROTEIN , and PROTEIN but interacts poorly with PROTEIN2 .
0	We demonstrate that PROTEIN surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the PROTEIN1 ( PROTEIN ) and PROTEIN , and that PROTEIN2 expression is TAP-dependent and tapasin-dependent .
0	We used alanine substitution of PROTEIN residues that contact PROTEIN in the crystal structure to investigate the function of these residues in both PROTEIN and PROTEIN1PROTEIN2 in the crystal structure to investigate the function of these residues in both PROTEIN and PROTEIN binding .
0	PROTEIN1 is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN2-Cdk2 , cyclin E-Cdk2 , cyclin D1-Cdk4 , and cyclin D2-Cdk4 complexes .
0	Expression of PROTEIN1 IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including PROTEIN2 , -2 , -4 , and -6 , while PROTEIN IIIb-expressing cells responded only to PROTEIN .
1	In addition , PROTEIN1 dissociates from PROTEIN2 upon binding of MHC class I leader sequence peptides .
1	The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ( PROTEIN , PROTEIN1/MORT , RIP , FLICE/MACH , and TRAFs ) associated with both of the PROTEIN2 and PROTEIN forms of the TNF receptor and with other members of the TNF receptor superfamily .
0	In vitro experiments showed that the stable Grb2/c-Cbl complex interacts , through the PROTEIN SH2 domain , with the SCF-activated PROTEIN1PROTEIN2 complex interacts , through the PROTEIN SH2 domain , with the SCF-activated PROTEIN .
0	In vitro experiments showed that the stable Grb2/c-Cbl complex interacts , through the PROTEIN SH2 domain , with the PROTEIN1PROTEIN2 SH2 domain , with the SCF-activated PROTEIN .
0	Two potentially oncogenic cyclins , PROTEIN1 and cyclin D1 , share common properties of subunit configuration , tyrosine phosphorylation and physical association with the PROTEIN protein .Originally identified as a 'mitotic cyclin ' , PROTEIN2 exhibits properties of growth factor sensitivity , susceptibility to viral subversion and association with a tumor-suppressor protein , properties which are indicative of an S-phase-promoting factor ( PROTEIN ) as well as a candidate proto-oncogene .
0	Shared and unique determinants of the PROTEIN1PROTEIN2 ) receptor are important for binding PROTEIN and PROTEIN mimetic peptide .
1	Analysis of the human PROTEIN1/human PROTEIN2 binding interface at the amino acid level : proposed mechanism of interaction .
1	Here we report that ( 1 ) there is an accumulation of PROTEIN protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription ; ( 2 ) addition of PROTEIN to an in vitro transcription system inhibits transcription by RNA polymerase I ; ( 3 ) this inhibition requires a functional PROTEIN pocket ; and ( 4 ) PROTEIN1 specifically inhibits the activity of the RNA polymerase I transcription factor PROTEIN ( PROTEIN2 ) in vitro .
0	In order to characterize the signaling pathway through which PROTEIN regulates cell growth , L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms , PROTEIN1PROTEIN2 IIIb and PROTEIN IIIc , that result from alternative splicing of exon III of the PROTEIN gene encoding the ligand binding domain .
0	A protein ligand for the PROTEIN receptor protein-tyrosine kinase has been isolated by using the extracellular domain ( PROTEIN1PROTEIN2 has been isolated by using the extracellular domain ( ECK-X ) of the receptor as an affinity reagent .
0	Analysis of the human interleukin-6/human PROTEIN1PROTEIN2 receptor binding interface at the amino acid level : proposed mechanism of interaction .
0	PROTEIN is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN1-Cdk2 , cyclin E-PROTEIN2 , cyclin D1-Cdk4 , and cyclin D2-Cdk4 complexes .
1	Taken together our results demonstrate that PROTEIN plays an important role in coupling both tyrosine and non-tyrosine kinase receptors to downstream effector molecules and that different signaling molecules interact with PROTEIN1/PROTEIN2 complex when non-tyrosine or tyrosine kinase receptors are activated .
1	The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ( PROTEIN , FADD/MORT , RIP , FLICE/PROTEIN1 , and TRAFs ) associated with both of the PROTEIN and PROTEIN2 forms of the TNF receptor and with other members of the TNF receptor superfamily .
0	PROTEIN is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by cyclin A-Cdk2 , cyclin E-Cdk2 , cyclin D1-PROTEIN1 , and PROTEIN2-Cdk4 complexes .
0	PROTEIN is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by cyclin A-Cdk2 , PROTEIN1-Cdk2 , cyclin D1-PROTEIN2 , and cyclin D2-Cdk4 complexes .
0	Two potentially oncogenic cyclins , PROTEIN1 and cyclin D1 , share common properties of subunit configuration , tyrosine phosphorylation and physical association with the PROTEIN protein .Originally identified as a 'mitotic cyclin ' , cyclin A exhibits properties of growth factor sensitivity , susceptibility to viral subversion and association with a tumor-suppressor protein , properties which are indicative of an PROTEIN2 ( PROTEIN ) as well as a candidate proto-oncogene .
0	By contrast the PROTEIN exchanger factor ( PROTEIN ) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and PROTEIN1PROTEIN2 ) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and Grb2/c-Cbl are present in different complexes .
0	In agreement , mAb to the previously cloned PROTEIN were found to stain unstimulated T cells that express only the PROTEIN1 PROTEIN but not T-cell clones that express predominantly the PROTEIN PROTEIN2 .
0	The receptor chains bind to the 'wrist ' epitopes of the PROTEIN1 dimer and contact both PROTEIN2 monomers .
0	In agreement , mAb to the previously cloned PROTEIN were found to stain unstimulated T cells that express only the PROTEIN1PROTEIN2 were found to stain unstimulated T cells that express only the PROTEIN PROTEIN but not T-cell clones that express predominantly the PROTEIN PROTEIN .
0	PROTEIN is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by cyclin A-PROTEIN1 , PROTEIN2-Cdk2 , cyclin D1-Cdk4 , and cyclin D2-Cdk4 complexes .
0	Transcription factor PROTEIN consists of TATA binding protein ( PROTEIN ) and at least eight PROTEIN1PROTEIN2 ( PROTEIN ) and at least eight TBP-associated factors ( TAFs ) .
0	Our results indicate that Phe93 and Phe205 are important for both PROTEIN and PROTEIN binding , Met150 is not important for PROTEIN1PROTEIN2 binding , Met150 is not important for PROTEIN binding but is critical for PROTEIN binding , and Thr151 is not important for binding either ligand .
0	By using the growth factor dependent M-07e cell line , we found that both PROTEIN1 and PROTEIN ligands , namely : PROTEIN and PROTEIN2 , induce PROTEIN tyrosine phosphorylation .
0	Moreover , PROTEIN1 was found to be phosphorylated on tyrosine residues in vivo and , like PROTEIN2 , was readily phosphorylated by pp60c-src in vitro .
0	The PROTEIN1 Cdk-interacting protein PROTEIN2 is a potent inhibitor of G1 cyclin-dependent kinases .
0	Remarkably , Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the PROTEIN bound to an EPO-mimetic peptide ( PROTEIN1PROTEIN2 ( PROTEIN ) , suggesting that Phe93 is also important for PROTEIN binding .
1	We used alanine substitution of PROTEIN1 residues that contact PROTEIN in the crystal structure to investigate the function of these residues in both PROTEIN and PROTEIN2 binding .
1	We demonstrate that PROTEIN surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN1 associates with the transporter associated with antigen processing ( PROTEIN2 ) and PROTEIN , and that PROTEIN expression is TAP-dependent and tapasin-dependent .
0	The cyclin-dependent kinase PROTEIN1 associates with PROTEIN2 , D , and E and has been implicated in the control of the G1 to S phase transition in mammals .
0	PROTEIN1 recognizes one FGFR isoform known as the PROTEIN IIIb isoform or keratinocyte growth factor receptor ( PROTEIN ) , whereas PROTEIN binds well to PROTEIN , PROTEIN , and PROTEIN2 but interacts poorly with PROTEIN .
0	Shared and unique determinants of the PROTEIN ( PROTEIN ) receptor are important for binding PROTEIN and PROTEIN1PROTEIN2 ) receptor are important for binding PROTEIN and PROTEIN mimetic peptide .
0	We report here that recombinant PROTEIN1 induces autophosphorylation of PROTEIN in intact cells , consistent with PROTEIN being an authentic ligand for PROTEIN2 .
0	By contrast the PROTEIN exchanger factor ( PROTEIN ) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and PROTEIN1PROTEIN2 immunoprecipitates suggesting that Grb2/Sos1 and Grb2/c-Cbl are present in different complexes .
0	Here , we demonstrate that PROTEIN may regulate the activity of the HIV-1 long terminal repeat through its ability to bind sequences in the PROTEIN enhancer region and to interact with the PROTEIN subunit , PROTEIN1PROTEIN2 enhancer region and to interact with the PROTEIN subunit , PROTEIN .
0	We report here that recombinant PROTEIN induces autophosphorylation of PROTEIN1 in intact cells , consistent with PROTEIN2 being an authentic ligand for PROTEIN .
0	In this article , we demonstrate that PROTEIN associates with a complex containing PROTEIN1- and PROTEIN2 in mink lung ( MvLu ) cells , and in rat heart , lung , and brain tissues .
1	Here we report that ( 1 ) there is an accumulation of PROTEIN protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription ; ( 2 ) addition of PROTEIN to an in vitro transcription system inhibits transcription by RNA polymerase I ; ( 3 ) this inhibition requires a functional PROTEIN pocket ; and ( 4 ) PROTEIN1 specifically inhibits the activity of the RNA polymerase I transcription factor PROTEIN2 ( upstream binding factor ) in vitro .
0	PROTEIN recognizes one FGFR isoform known as the PROTEIN IIIb isoform or keratinocyte growth factor receptor ( PROTEIN ) , whereas PROTEIN1PROTEIN2 isoform or keratinocyte growth factor receptor ( PROTEIN ) , whereas PROTEIN binds well to PROTEIN , PROTEIN , and PROTEIN but interacts poorly with PROTEIN .
1	Furthermore , PROTEIN blocks the ability of PROTEIN1 to activate PROTEIN2 , the principal replicative DNA polymerase .
0	PROTEIN1 is a ligand for the PROTEIN2 receptor protein-tyrosine kinase .
0	Two lines of evidence support the notion that PROTEIN and simian virus 40 T antigen have homologous PROTEIN1-binding properties : first , several mutated PROTEIN proteins that failed to bind to T also did not associate with PROTEIN ; and second , both T antigen and T peptide ( amino acids 101-118 ) were able to compete with PROTEIN2 for binding to PROTEIN .
0	PROTEIN is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by cyclin A-Cdk2 , PROTEIN1-Cdk2 , cyclin D1-Cdk4 , and cyclin D2-PROTEIN2 complexes .
1	Significantly , PROTEIN1 partially activates PROTEIN2 and potentiates the activation caused by UV .
0	Moreover we found that , upon PROTEIN stimulation , the Grb2/c-Cbl complex recruits PROTEIN1PROTEIN2 complex recruits PROTEIN , probably via PROTEIN .
0	We have shown previously that Phe93 in the extracellular domain of the PROTEIN ( PROTEIN ) receptor ( PROTEIN ) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN1 ( EPO-binding protein or PROTEIN2 ) and no detectable binding to full-length mutant receptor expressed in COS cells .
0	PROTEIN in complex with a previously identified 90-kDa protein and designated protein PROTEIN1PROTEIN2 in complex with a previously identified 90-kDa protein and designated protein PROTEIN .
0	PROTEIN recognizes one FGFR isoform known as the PROTEIN IIIb isoform or keratinocyte growth factor receptor ( PROTEIN ) , whereas PROTEIN binds well to PROTEIN1 , PROTEIN , and PROTEIN but interacts poorly with PROTEIN2 .
0	We have shown previously that Phe93 in the extracellular domain of the PROTEIN ( PROTEIN1 ) receptor ( PROTEIN ) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( EPO-binding protein or PROTEIN2 ) and no detectable binding to full-length mutant receptor expressed in COS cells .
0	PROTEIN1 utilizes two different pools of adapter protein PROTEIN2 to link to PROTEIN .
1	The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ( PROTEIN1 , FADD/MORT , RIP , FLICE/MACH , and TRAFs ) associated with both of the PROTEIN2 and PROTEIN forms of the TNF receptor and with other members of the TNF receptor superfamily .
0	We demonstrate that PROTEIN surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the transporter associated with antigen processing ( PROTEIN ) and PROTEIN , and that PROTEIN1PROTEIN2 with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the transporter associated with antigen processing ( PROTEIN ) and PROTEIN , and that PROTEIN expression is TAP-dependent and tapasin-dependent .
0	We demonstrate that PROTEIN1 surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the PROTEIN2 ( PROTEIN ) and PROTEIN , and that PROTEIN expression is TAP-dependent and tapasin-dependent .
0	PROTEIN recognizes one FGFR isoform known as the PROTEIN IIIb isoform or PROTEIN1PROTEIN2 isoform or keratinocyte growth factor receptor ( PROTEIN ) , whereas PROTEIN binds well to PROTEIN , PROTEIN , and PROTEIN but interacts poorly with PROTEIN .
1	Cross-family dimerization of transcription factors Fos/Jun and PROTEIN1/PROTEIN2 alters DNA binding specificity .
0	PROTEIN recognizes one FGFR isoform known as the PROTEIN IIIb isoform or PROTEIN1 ( PROTEIN ) , whereas PROTEIN binds well to PROTEIN , PROTEIN , and PROTEIN but interacts poorly with PROTEIN2 .
0	We have shown previously that Phe93 in the extracellular domain of the PROTEIN ( PROTEIN1 ) receptor ( PROTEIN ) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN2 ( EPO-binding protein or PROTEIN ) and no detectable binding to full-length mutant receptor expressed in COS cells .
0	In vitro experiments showed that the stable Grb2/c-Cbl complex interacts , through the PROTEIN SH2 domain , with the PROTEIN1PROTEIN2/c-Cbl complex interacts , through the PROTEIN SH2 domain , with the SCF-activated PROTEIN .
0	In summary , PROTEIN signaling pathway utilizes two PROTEIN1-containing complexes ; PROTEIN2 .
0	PROTEIN1 is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by cyclin A-Cdk2 , cyclin E-Cdk2 , cyclin D1-PROTEIN2 , and cyclin D2-Cdk4 complexes .
0	In vitro transcription assay demonstrates that PROTEIN1 represses PROTEIN2 mediated transcription in a cell-free system .
0	Most familial early-onset Alzheimer 's disease cases are caused by mutations in the presenilin 1 ( PROTEIN1PROTEIN2 ( PROTEIN ) gene .
0	Shared and unique determinants of the PROTEIN ( PROTEIN ) receptor are important for binding PROTEIN and PROTEIN1PROTEIN2 ( PROTEIN ) receptor are important for binding PROTEIN and PROTEIN mimetic peptide .
0	PROTEIN is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by cyclin A-Cdk2 , PROTEIN1-Cdk2 , cyclin D1-Cdk4 , and PROTEIN2-Cdk4 complexes .
0	Shared and unique determinants of the PROTEIN ( PROTEIN ) receptor are important for binding PROTEIN and PROTEIN1PROTEIN2 are important for binding PROTEIN and PROTEIN mimetic peptide .
0	We report here that recombinant PROTEIN1 induces autophosphorylation of PROTEIN in intact cells , consistent with PROTEIN2 being an authentic ligand for PROTEIN .
1	The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ( PROTEIN , FADD/PROTEIN1 , RIP , FLICE/MACH , and TRAFs ) associated with both of the PROTEIN and PROTEIN2 forms of the TNF receptor and with other members of the TNF receptor superfamily .
0	Here we report the crystal structure of human dimeric PROTEIN in complex with two high affinity PROTEIN1s ( PROTEIN2 ) .
1	By utilizing domain swapping and site-directed mutagenesis we have found that the loop connecting the beta4-beta5 strands of PROTEIN1 contributes to high affinity receptor binding and is critical for PROTEIN2 recognition .
0	We demonstrate that PROTEIN surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the PROTEIN1 ( PROTEIN ) and PROTEIN2 , and that PROTEIN expression is TAP-dependent and tapasin-dependent .
0	The interaction between PROTEIN ( PROTEIN ) and PROTEIN1PROTEIN2 ( PROTEIN ) is the initial and most specific step in the PROTEIN signaling pathway .
0	Remarkably , Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the PROTEIN bound to an PROTEIN1PROTEIN2 ( PROTEIN ) , suggesting that Phe93 is also important for PROTEIN binding .
0	Moreover we found that , upon PROTEIN stimulation , the Grb2/c-Cbl complex recruits PROTEIN , probably via PROTEIN1PROTEIN2 complex recruits PROTEIN , probably via PROTEIN .
0	We demonstrate that PROTEIN surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN1PROTEIN2 with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the transporter associated with antigen processing ( PROTEIN ) and PROTEIN , and that PROTEIN expression is TAP-dependent and tapasin-dependent .
0	The interaction between PROTEIN ( PROTEIN ) and PROTEIN1 receptor ( PROTEIN ) is the initial and most specific step in the PROTEIN2 signaling pathway .
0	Discrete protein interactions with the Grb2/c-Cbl complex in SCF- and PROTEIN1PROTEIN2 complex in SCF- and TPO-mediated myeloid cell proliferation .
0	We have shown previously that Phe93 in the extracellular domain of the PROTEIN1 ( PROTEIN2 ) receptor ( PROTEIN ) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( EPO-binding protein or PROTEIN ) and no detectable binding to full-length mutant receptor expressed in COS cells .
0	PROTEIN is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by cyclin A-Cdk2 , cyclin E-PROTEIN1 , cyclin D1-Cdk4 , and PROTEIN2-Cdk4 complexes .
0	We have shown previously that Phe93 in the extracellular domain of the PROTEIN ( PROTEIN ) receptor ( PROTEIN ) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN1PROTEIN2 or PROTEIN ) and no detectable binding to full-length mutant receptor expressed in COS cells .
0	In vitro protein-protein interaction assays reveal that as observed with Drosophila PROTEIN1 , PROTEIN interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator viral protein 16 ( PROTEIN ) as well as with the general transcription factor PROTEIN2 .
0	These data demonstrate that the PROTEIN PROTEIN is the T-cell homologue of the cloned PROTEIN , and imply that the PROTEIN and PROTEIN1PROTEIN2 is the T-cell homologue of the cloned PROTEIN , and imply that the PROTEIN and PROTEIN PROTEIN have different extracellular domains .
0	In agreement , mAb to the previously cloned PROTEIN were found to stain unstimulated T cells that express only the PROTEIN1 PROTEIN but not T-cell clones that express predominantly the PROTEIN2 PROTEIN .
0	PROTEIN is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by cyclin A-Cdk2 , cyclin E-PROTEIN1 , PROTEIN2-Cdk4 , and cyclin D2-Cdk4 complexes .
1	A protein , PROTEIN1 ( PROTEIN ) , was identified in a human cell line that bound to a region of the epidermal growth factor receptor ( PROTEIN2 ) containing the lysosomal targeting code .
0	Shared and unique determinants of the PROTEIN ( PROTEIN ) receptor are important for binding PROTEIN1 and PROTEIN2 mimetic peptide .
0	PROTEIN1 is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by cyclin A-Cdk2 , cyclin E-Cdk2 , cyclin D1-Cdk4 , and cyclin D2-PROTEIN2 complexes .
0	In order to characterize the signaling pathway through which PROTEIN regulates cell growth , L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms , PROTEIN1 IIIb and PROTEIN2 , that result from alternative splicing of exon III of the PROTEIN gene encoding the ligand binding domain .
0	The interaction between PROTEIN ( PROTEIN ) and PROTEIN receptor ( PROTEIN1 ) is the initial and most specific step in the PROTEIN2 signaling pathway .
0	Immunoprecipitation experiments with human osteosarcoma cells and Ewing 's sarcoma cells demonstrated that cyclin D1 is associated with both PROTEIN1 and PROTEIN2 , and that cyclin D1 immune complexes exhibit appreciable histone H1 kinase activity .
1	In vitro experiments showed that the stable Grb2/c-Cbl complex interacts , through the PROTEIN1 SH2 domain , with the SCF-activated PROTEIN2 .
0	In the present study we evaluated tyrosine phosphorylation of PROTEIN and the interaction of the Grb2/PROTEIN1 complex with signaling proteins upon activation of non-tyrosine ( PROTEIN2 ) and tyrosine kinase ( PROTEIN ) receptors leading to myeloid cell proliferation .
1	A protein , sorting nexin-1 ( PROTEIN1 ) , was identified in a human cell line that bound to a region of the PROTEIN2 ( PROTEIN ) containing the lysosomal targeting code .
0	We demonstrate that PROTEIN surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the PROTEIN1 ( PROTEIN2 ) and PROTEIN , and that PROTEIN expression is TAP-dependent and tapasin-dependent .
0	In order to characterize the signaling pathway through which PROTEIN regulates cell growth , L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms , PROTEIN1 and PROTEIN2 , that result from alternative splicing of exon III of the PROTEIN gene encoding the ligand binding domain .
0	Transcription factor PROTEIN consists of TATA binding protein ( PROTEIN ) and at least eight PROTEIN1PROTEIN2 consists of TATA binding protein ( PROTEIN ) and at least eight TBP-associated factors ( TAFs ) .
1	Cell surface PROTEIN1 formed complexes in vivo with actin-binding protein PROTEIN ( PROTEIN2 ) , which is known to form bridges between cell surface receptors and cytoskeleton and mediate cell adhesion and cell motility .
0	Expression of PROTEIN1 in stably transfected L6 cells conferred growth responses to several members of the FGF family including PROTEIN , -2 , -4 , and -6 , while PROTEIN2-expressing cells responded only to PROTEIN .
0	PROTEIN1 is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by cyclin A-Cdk2 , cyclin E-Cdk2 , PROTEIN2-Cdk4 , and cyclin D2-Cdk4 complexes .
0	In vitro experiments showed that the stable Grb2/c-Cbl complex interacts , through the PROTEIN1PROTEIN2/c-Cbl complex interacts , through the PROTEIN SH2 domain , with the SCF-activated PROTEIN .
0	Moreover we found that , upon PROTEIN stimulation , the Grb2/c-Cbl complex recruits PROTEIN1PROTEIN2 stimulation , the Grb2/c-Cbl complex recruits PROTEIN , probably via PROTEIN .
0	Molecular cloning and expression of the 32-kDa subunit of human PROTEIN1 reveals interactions with PROTEIN and PROTEIN2 that mediate transcriptional activation .
0	Discrete protein interactions with the Grb2/c-Cbl complex in PROTEIN1PROTEIN2 complex in SCF- and TPO-mediated myeloid cell proliferation .
0	A protein ligand for the PROTEIN1PROTEIN2 has been isolated by using the extracellular domain ( ECK-X ) of the receptor as an affinity reagent .
0	By contrast the PROTEIN exchanger factor ( PROTEIN ) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and Grb2/PROTEIN1PROTEIN2 and Grb2/c-Cbl are present in different complexes .
0	In order to characterize the signaling pathway through which PROTEIN regulates cell growth , L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms , PROTEIN IIIb and PROTEIN1PROTEIN2 IIIb and PROTEIN IIIc , that result from alternative splicing of exon III of the PROTEIN gene encoding the ligand binding domain .
1	Our finding that PROTEIN1 directly interacts with PROTEIN2 ( PROTEIN ) , a common subunit of RNA polymerases , implies that PROTEIN directly modulates the function of RNA polymerase ( Cheong , J. H. , Yi , M. , Lin , Y. , and Murakami , S. ( 1995 ) EMBO J .
0	Functional studies in Jurkat T lymphocytic cells point to the importance of both the PROTEIN and PROTEIN binding sites in PROTEIN1PROTEIN2 and PROTEIN binding sites in PROTEIN mediated repression of HIV-1 promoter , in vivo .
0	In order to characterize the signaling pathway through which PROTEIN regulates cell growth , L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms , PROTEIN1PROTEIN2 regulates cell growth , L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms , PROTEIN IIIb and PROTEIN IIIc , that result from alternative splicing of exon III of the PROTEIN gene encoding the ligand binding domain .
0	We have shown previously that Phe93 in the extracellular domain of the PROTEIN1 ( PROTEIN ) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( EPO-binding protein or PROTEIN2 ) and no detectable binding to full-length mutant receptor expressed in COS cells .
1	We demonstrate that PROTEIN surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN1 associates with the PROTEIN2 ( PROTEIN ) and PROTEIN , and that PROTEIN expression is TAP-dependent and tapasin-dependent .
0	In vitro and in vivo experiments support the hypothesis that PROTEIN mediates the association of PROTEIN with PROTEIN1PROTEIN2 mediates the association of PROTEIN with PROTEIN .
0	We have shown previously that Phe93 in the extracellular domain of the PROTEIN1 ( PROTEIN ) receptor ( PROTEIN ) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( EPO-binding protein or PROTEIN2 ) and no detectable binding to full-length mutant receptor expressed in COS cells .
0	PROTEIN is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by cyclin A-Cdk2 , cyclin E-PROTEIN1 , cyclin D1-PROTEIN2 , and cyclin D2-Cdk4 complexes .
0	PROTEIN recognizes one FGFR isoform known as the PROTEIN IIIb isoform or PROTEIN1PROTEIN2 recognizes one FGFR isoform known as the PROTEIN IIIb isoform or keratinocyte growth factor receptor ( PROTEIN ) , whereas PROTEIN binds well to PROTEIN , PROTEIN , and PROTEIN but interacts poorly with PROTEIN .
0	The ultraviolet ( UV ) response of mammalian cells is characterized by a rapid and selective increase in gene expression mediated by PROTEIN1 and PROTEIN2 .
1	By using the growth factor dependent M-07e cell line , we found that both PROTEIN and PROTEIN ligands , namely : PROTEIN1 and PROTEIN , induce PROTEIN2 tyrosine phosphorylation .
0	PROTEIN1 encodes a novel 21 kd protein that is found in cyclin A , cyclin D1 , cyclin E , and PROTEIN2 immunoprecipitates .
0	By contrast the PROTEIN exchanger factor ( PROTEIN ) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and PROTEIN1PROTEIN2/Sos1 and Grb2/c-Cbl are present in different complexes .
0	In the present study we evaluated tyrosine phosphorylation of PROTEIN1 and the interaction of the PROTEIN2/c-Cbl complex with signaling proteins upon activation of non-tyrosine ( PROTEIN ) and tyrosine kinase ( PROTEIN ) receptors leading to myeloid cell proliferation .
0	Deglycosylation studies showed that the PROTEIN and PROTEIN1PROTEIN2 and PROTEIN PROTEIN are not simply differently glycosylated isoforms of a single receptor .
1	PROTEIN1 : a protein kinase stimulated by UV light and PROTEIN that binds and phosphorylates the PROTEIN2 activation domain .
0	PROTEIN and PROTEIN1PROTEIN2 and 80K-H.pp66 .
0	Two lines of evidence support the notion that PROTEIN and simian virus 40 T antigen have homologous Rb-binding properties : first , several mutated PROTEIN1 proteins that failed to bind to T also did not associate with PROTEIN ; and second , both T antigen and T peptide ( amino acids 101-118 ) were able to compete with PROTEIN2 for binding to PROTEIN .
0	The interaction between PROTEIN ( PROTEIN ) and PROTEIN1PROTEIN2 ( PROTEIN ) and PROTEIN receptor ( PROTEIN ) is the initial and most specific step in the PROTEIN signaling pathway .
0	After pervanadate treatment of MvLu cells , which inhibits cellular tyrosine phosphatase activity including PROTEIN1 , the cadherins associated with PROTEIN2 are now found in a tyrosine-phosphorylated form , indicating that the cadherins may be an endogenous substrate for PROTEIN .
0	PROTEIN is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by cyclin A-PROTEIN1 , cyclin E-PROTEIN2 , cyclin D1-Cdk4 , and cyclin D2-Cdk4 complexes .
0	Taken together our results demonstrate that PROTEIN plays an important role in coupling both tyrosine and non-tyrosine kinase receptors to downstream effector molecules and that different signaling molecules interact with PROTEIN1PROTEIN2 plays an important role in coupling both tyrosine and non-tyrosine kinase receptors to downstream effector molecules and that different signaling molecules interact with Grb2/c-Cbl complex when non-tyrosine or tyrosine kinase receptors are activated .
0	PROTEIN1 is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by cyclin A-Cdk2 , cyclin E-PROTEIN2 , cyclin D1-Cdk4 , and cyclin D2-Cdk4 complexes .
0	PROTEIN is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN1 by cyclin A-PROTEIN2 , cyclin E-Cdk2 , cyclin D1-Cdk4 , and cyclin D2-Cdk4 complexes .
0	PROTEIN1 encodes a novel 21 kd protein that is found in PROTEIN2 , cyclin D1 , cyclin E , and PROTEIN immunoprecipitates .
1	Instead , 14-3-3 may facilitate the association of PROTEIN1 with PROTEIN2 in vivo , participating in the linkage between mitogenic signaling and the cell cycle machinery .
0	We have shown previously that Phe93 in the extracellular domain of the PROTEIN ( PROTEIN1 ) receptor ( PROTEIN ) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN2 or PROTEIN ) and no detectable binding to full-length mutant receptor expressed in COS cells .
0	We have previously demonstrated such changes by affinity cross-linking studies , and have shown that unstimulated human T cells express a single PROTEIN1 of 90 kDa , whereas activated T cells express an additional 76-kDa PROTEIN2 binding protein .
0	PROTEIN1 is a member of a large orphan receptor protein-tyrosine kinase family headed by EPH , and we suggest that ligands for other members of this family will be related to PROTEIN2 , and can be isolated in the same way .
1	Moreover we found that , upon PROTEIN stimulation , the PROTEIN1/PROTEIN2 complex recruits PROTEIN , probably via PROTEIN .
0	Finally , activated PROTEIN was also found to result in phosphorylation of PROTEIN1 but reduced phosphorylation of PROTEIN2 .
1	A protein , PROTEIN1 ( PROTEIN ) , was identified in a human cell line that bound to a region of the PROTEIN2 ( PROTEIN ) containing the lysosomal targeting code .
0	These data demonstrate that the PROTEIN PROTEIN is the T-cell homologue of the cloned PROTEIN , and imply that the PROTEIN and PROTEIN1PROTEIN2 , and imply that the PROTEIN and PROTEIN PROTEIN have different extracellular domains .
0	PROTEIN1 is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN2 by cyclin A-Cdk2 , cyclin E-Cdk2 , cyclin D1-Cdk4 , and cyclin D2-Cdk4 complexes .
0	PROTEIN recognizes one FGFR isoform known as the PROTEIN IIIb isoform or keratinocyte growth factor receptor ( PROTEIN ) , whereas PROTEIN binds well to PROTEIN1 , PROTEIN2 , and PROTEIN but interacts poorly with PROTEIN .
0	PROTEIN recognizes one FGFR isoform known as the PROTEIN IIIb isoform or keratinocyte growth factor receptor ( PROTEIN ) , whereas PROTEIN binds well to PROTEIN1 , PROTEIN , and PROTEIN2 but interacts poorly with PROTEIN .
0	TAP- and tapasin-dependent PROTEIN1PROTEIN2-dependent PROTEIN surface expression correlates with the binding of an MHC class I leader peptide .
0	Although numerous studies revealed predominant localization of PROTEIN to endoplasmic reticulum and Golgi , there are conflicting reports on the localization of PROTEIN1PROTEIN2 to endoplasmic reticulum and Golgi , there are conflicting reports on the localization of PROTEIN to the cell surface .
0	Expression of PROTEIN1 IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including PROTEIN , -2 , -4 , and -6 , while PROTEIN2 IIIb-expressing cells responded only to PROTEIN .
0	PROTEIN is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN1-Cdk2 , cyclin E-Cdk2 , PROTEIN2-Cdk4 , and cyclin D2-Cdk4 complexes .
0	In the present study we evaluated tyrosine phosphorylation of PROTEIN1 and the interaction of the Grb2/c-Cbl complex with signaling proteins upon activation of non-tyrosine ( PROTEIN ) and tyrosine kinase ( PROTEIN2 ) receptors leading to myeloid cell proliferation .
0	The interaction between PROTEIN ( PROTEIN1 ) and PROTEIN receptor ( PROTEIN ) is the initial and most specific step in the PROTEIN2 signaling pathway .
0	In the present study we evaluated tyrosine phosphorylation of PROTEIN1 and the interaction of the Grb2/c-Cbl complex with signaling proteins upon activation of non-tyrosine ( PROTEIN2 ) and tyrosine kinase ( PROTEIN ) receptors leading to myeloid cell proliferation .
0	The interaction between PROTEIN ( PROTEIN ) and PROTEIN1PROTEIN2 ) and PROTEIN receptor ( PROTEIN ) is the initial and most specific step in the PROTEIN signaling pathway .
0	Taken together our results demonstrate that PROTEIN1 plays an important role in coupling both tyrosine and non-tyrosine kinase receptors to downstream effector molecules and that different signaling molecules interact with Grb2/PROTEIN2 complex when non-tyrosine or tyrosine kinase receptors are activated .
0	The correlation between PROTEIN and MHC class I surface expression might be relevant to the function of HLA-E. Our results also show that , although these PROTEIN1PROTEIN2 .
1	Furthermore , PROTEIN1 blocks the ability of PROTEIN2 to activate DNA polymerase delta , the principal replicative DNA polymerase .
1	The reciprocal loop replacement mutant ( FGF2-L4/7 ) retained PROTEIN1 like affinity for PROTEIN and for PROTEIN2 .
0	By contrast the PROTEIN exchanger factor ( PROTEIN ) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and Grb2/PROTEIN1PROTEIN2 ) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and Grb2/c-Cbl are present in different complexes .
0	Tyrosine phophorylation of the 66-kDa protein was dependent on ligand activation of PROTEIN , suggesting that the 66-kDa protein may play an important role in PROTEIN1PROTEIN2 , suggesting that the 66-kDa protein may play an important role in FGFR3-specific signaling .
0	Our results indicate that Phe93 and Phe205 are important for both PROTEIN and PROTEIN1PROTEIN2 and PROTEIN binding , Met150 is not important for PROTEIN binding but is critical for PROTEIN binding , and Thr151 is not important for binding either ligand .
0	PROTEIN recognizes one FGFR isoform known as the PROTEIN IIIb isoform or PROTEIN1 ( PROTEIN ) , whereas PROTEIN binds well to PROTEIN2 , PROTEIN , and PROTEIN but interacts poorly with PROTEIN .
0	In order to characterize the signaling pathway through which PROTEIN regulates cell growth , L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms , PROTEIN1 and PROTEIN2 IIIc , that result from alternative splicing of exon III of the PROTEIN gene encoding the ligand binding domain .
0	PROTEIN recognizes one FGFR isoform known as the PROTEIN IIIb isoform or keratinocyte growth factor receptor ( PROTEIN ) , whereas PROTEIN1PROTEIN2 recognizes one FGFR isoform known as the PROTEIN IIIb isoform or keratinocyte growth factor receptor ( PROTEIN ) , whereas PROTEIN binds well to PROTEIN , PROTEIN , and PROTEIN but interacts poorly with PROTEIN .
0	These data demonstrate that the PROTEIN PROTEIN is the T-cell homologue of the cloned PROTEIN , and imply that the PROTEIN1PROTEIN2 is the T-cell homologue of the cloned PROTEIN , and imply that the PROTEIN and PROTEIN PROTEIN have different extracellular domains .
0	In addition to this unique pathway , PROTEIN1 also links to PROTEIN2 .
0	PROTEIN is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN1 by cyclin A-Cdk2 , cyclin E-Cdk2 , PROTEIN2-Cdk4 , and cyclin D2-Cdk4 complexes .
0	We demonstrate that PROTEIN surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the transporter associated with antigen processing ( PROTEIN1 ) and PROTEIN , and that PROTEIN expression is PROTEIN2-dependent and tapasin-dependent .
0	We have shown previously that Phe93 in the extracellular domain of the PROTEIN ( PROTEIN ) receptor ( PROTEIN ) is crucial for binding PROTEIN1.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN2 or PROTEIN ) and no detectable binding to full-length mutant receptor expressed in COS cells .
0	The correlation between PROTEIN and MHC class I surface expression might be relevant to the function of HLA-E. Our results also show that , although these PROTEIN binding peptides are derived from signal sequences , they may be released back into the cytosol and subsequently translocated by the PROTEIN1PROTEIN2 and MHC class I surface expression might be relevant to the function of HLA-E. Our results also show that , although these PROTEIN binding peptides are derived from signal sequences , they may be released back into the cytosol and subsequently translocated by the PROTEIN complex and loaded onto PROTEIN molecules .
0	PROTEIN encodes a novel 21 kd protein that is found in PROTEIN1 , cyclin D1 , cyclin E , and PROTEIN2 immunoprecipitates .
0	PROTEIN recognizes one FGFR isoform known as the PROTEIN IIIb isoform or keratinocyte growth factor receptor ( PROTEIN ) , whereas PROTEIN binds well to PROTEIN , PROTEIN1PROTEIN2 recognizes one FGFR isoform known as the PROTEIN IIIb isoform or keratinocyte growth factor receptor ( PROTEIN ) , whereas PROTEIN binds well to PROTEIN , PROTEIN , and PROTEIN but interacts poorly with PROTEIN .
0	PROTEIN is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN1 by cyclin A-Cdk2 , PROTEIN2-Cdk2 , cyclin D1-Cdk4 , and cyclin D2-Cdk4 complexes .
1	The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ( PROTEIN , FADD/MORT , RIP , FLICE/PROTEIN1 , and TRAFs ) associated with both of the PROTEIN2 and PROTEIN forms of the TNF receptor and with other members of the TNF receptor superfamily .
0	Molecular cloning and expression of the 32-kDa subunit of human PROTEIN1 reveals interactions with PROTEIN2 and PROTEIN that mediate transcriptional activation .
0	PROTEIN1- and tapasin-dependent PROTEIN2 surface expression correlates with the binding of an MHC class I leader peptide .
0	PROTEIN1 encodes a novel 21 kd protein that is found in cyclin A , cyclin D1 , PROTEIN2 , and PROTEIN immunoprecipitates .
0	In vitro binding studies demonstrated that the intracellular segment of PROTEIN binds directly to the intracellular domain of PROTEIN1 , but not to alpha- or PROTEIN2 .
1	Moreover we found that , upon PROTEIN stimulation , the Grb2/c-Cbl complex recruits PROTEIN1 , probably via PROTEIN2 .
0	In vitro protein-protein interaction assays reveal that as observed with Drosophila PROTEIN1 , PROTEIN interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator PROTEIN2 ( PROTEIN ) as well as with the general transcription factor PROTEIN .
0	Stimulation of fibroblast growth factor receptor 3 ( PROTEIN1PROTEIN2 ( PROTEIN ) results in a variety of functional effects , including regulation of epithelial cell growth and differentiation .
0	PROTEIN recognizes one FGFR isoform known as the PROTEIN IIIb isoform or keratinocyte growth factor receptor ( PROTEIN1 ) , whereas PROTEIN2 binds well to PROTEIN , PROTEIN , and PROTEIN but interacts poorly with PROTEIN .
0	Expression of PROTEIN IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including PROTEIN1 , -2 , -4 , and -6 , while PROTEIN2-expressing cells responded only to PROTEIN .
0	PROTEIN is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by cyclin A-PROTEIN1 , cyclin E-Cdk2 , PROTEIN2-Cdk4 , and cyclin D2-Cdk4 complexes .
0	Other recent studies have identified human PROTEIN1 ( PROTEIN2 ) as a putative G1 cyclin and candidate proto-oncogene .
0	We demonstrate that PROTEIN surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the PROTEIN1PROTEIN2 .
0	In summary , PROTEIN1 signaling pathway utilizes two PROTEIN2-containing complexes ; PROTEIN .
0	Replacement of this loop with the homologous loop from PROTEIN dramatically reduced both the affinity of PROTEIN for PROTEIN and its biological potency but did not result in the ability to bind PROTEIN1PROTEIN2 dramatically reduced both the affinity of PROTEIN for PROTEIN and its biological potency but did not result in the ability to bind PROTEIN .
0	By contrast the PROTEIN exchanger factor ( PROTEIN ) was not detected in anti-PROTEIN1 immunoprecipitates suggesting that Grb2/PROTEIN2 and Grb2/c-Cbl are present in different complexes .
0	PROTEIN encodes a novel 21 kd protein that is found in PROTEIN1 , PROTEIN2 , cyclin E , and PROTEIN immunoprecipitates .
0	Two potentially oncogenic cyclins , cyclin A and cyclin D1 , share common properties of subunit configuration , tyrosine phosphorylation and physical association with the PROTEIN1 protein .Originally identified as a 'mitotic cyclin ' , PROTEIN2 exhibits properties of growth factor sensitivity , susceptibility to viral subversion and association with a tumor-suppressor protein , properties which are indicative of an S-phase-promoting factor ( PROTEIN ) as well as a candidate proto-oncogene .
0	We demonstrate that PROTEIN1 surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the transporter associated with antigen processing ( PROTEIN ) and PROTEIN , and that PROTEIN expression is PROTEIN2-dependent and tapasin-dependent .
0	In vitro binding studies demonstrated that the intracellular segment of PROTEIN1 binds directly to the intracellular domain of PROTEIN , but not to alpha- or PROTEIN2 .
0	PROTEIN is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by cyclin A-Cdk2 , PROTEIN1-Cdk2 , PROTEIN2-Cdk4 , and cyclin D2-Cdk4 complexes .
0	In vitro protein-protein interaction assays reveal that as observed with Drosophila PROTEIN1 , PROTEIN interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator viral protein 16 ( PROTEIN2 ) as well as with the general transcription factor PROTEIN .
0	PROTEIN recognizes one FGFR isoform known as the PROTEIN IIIb isoform or keratinocyte growth factor receptor ( PROTEIN ) , whereas PROTEIN binds well to PROTEIN , PROTEIN1PROTEIN2 isoform or keratinocyte growth factor receptor ( PROTEIN ) , whereas PROTEIN binds well to PROTEIN , PROTEIN , and PROTEIN but interacts poorly with PROTEIN .
1	Remarkably , Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the PROTEIN1 bound to an EPO-mimetic peptide ( PROTEIN ) , suggesting that Phe93 is also important for PROTEIN2 binding .
0	PROTEIN recognizes one FGFR isoform known as the PROTEIN IIIb isoform or PROTEIN1 receptor ( PROTEIN ) , whereas PROTEIN binds well to PROTEIN , PROTEIN , and PROTEIN2 but interacts poorly with PROTEIN .
0	Expression of PROTEIN1PROTEIN2 in stably transfected L6 cells conferred growth responses to several members of the FGF family including PROTEIN , -2 , -4 , and -6 , while PROTEIN IIIb-expressing cells responded only to PROTEIN .
0	Finally , activated PROTEIN1 was also found to result in phosphorylation of PROTEIN2 but reduced phosphorylation of PROTEIN .
0	PROTEIN utilizes two different pools of adapter protein PROTEIN to link to PROTEIN1PROTEIN2 utilizes two different pools of adapter protein PROTEIN to link to PROTEIN .
0	After pervanadate treatment of MvLu cells , which inhibits cellular tyrosine phosphatase activity including PROTEIN , the cadherins associated with PROTEIN1 are now found in a tyrosine-phosphorylated form , indicating that the cadherins may be an endogenous substrate for PROTEIN2 .
1	We demonstrate that PROTEIN surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN1 associates with the transporter associated with antigen processing ( PROTEIN ) and PROTEIN2 , and that PROTEIN expression is TAP-dependent and tapasin-dependent .
0	In agreement , mAb to the previously cloned PROTEIN1 were found to stain unstimulated T cells that express only the PROTEIN PROTEIN but not T-cell clones that express predominantly the PROTEIN2 PROTEIN .
0	We used alanine substitution of PROTEIN residues that contact PROTEIN in the crystal structure to investigate the function of these residues in both PROTEIN1PROTEIN2 in the crystal structure to investigate the function of these residues in both PROTEIN and PROTEIN binding .
0	By contrast the PROTEIN exchanger factor ( PROTEIN ) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2/Sos1 and PROTEIN1PROTEIN2 and Grb2/c-Cbl are present in different complexes .
1	We studied the human PROTEIN ( PROTEIN1 ) /PROTEIN2 binding interface by a combination of molecular modelling and site-directed mutagenesis .
0	PROTEIN recognizes one FGFR isoform known as the PROTEIN IIIb isoform or keratinocyte growth factor receptor ( PROTEIN1 ) , whereas PROTEIN binds well to PROTEIN , PROTEIN , and PROTEIN2 but interacts poorly with PROTEIN .
0	PROTEIN1 : a protein kinase stimulated by UV light and PROTEIN2 that binds and phosphorylates the PROTEIN activation domain .
1	In vitro protein-protein interaction assays reveal that as observed with Drosophila PROTEIN , PROTEIN1 interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator PROTEIN2 ( PROTEIN ) as well as with the general transcription factor PROTEIN .
0	We demonstrate that PROTEIN surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the transporter associated with antigen processing ( PROTEIN1 ) and PROTEIN2 , and that PROTEIN expression is TAP-dependent and tapasin-dependent .
1	We have shown previously that Phe93 in the extracellular domain of the PROTEIN1 ( PROTEIN ) is crucial for binding PROTEIN2.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( EPO-binding protein or PROTEIN ) and no detectable binding to full-length mutant receptor expressed in COS cells .
0	PROTEIN encodes a novel 21 kd protein that is found in cyclin A , PROTEIN1 , PROTEIN2 , and PROTEIN immunoprecipitates .
0	By using the growth factor dependent M-07e cell line , we found that both PROTEIN1 and PROTEIN ligands , namely : PROTEIN2 and PROTEIN , induce PROTEIN tyrosine phosphorylation .
0	Activation of PROTEIN1 upon ligand binding resulted in activation of PROTEIN2 pathway .
0	PROTEIN is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN1 by cyclin A-Cdk2 , cyclin E-Cdk2 , cyclin D1-Cdk4 , and cyclin D2-PROTEIN2 complexes .
1	Some PROTEIN substitution mutants , which had severely impaired transacting activity , exhibited reduced binding affinity with either PROTEIN or PROTEIN in a mutually exclusive manner , suggesting that PROTEIN1 transactivation requires the interactions of both PROTEIN2 and PROTEIN .
1	PROTEIN is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by cyclin A-Cdk2 , PROTEIN1-PROTEIN2 , cyclin D1-Cdk4 , and cyclin D2-Cdk4 complexes .
0	Expression of PROTEIN1 in stably transfected L6 cells conferred growth responses to several members of the FGF family including PROTEIN , -2 , -4 , and -6 , while PROTEIN IIIb-expressing cells responded only to PROTEIN2 .
0	Our results indicate that Phe93 and Phe205 are important for both PROTEIN and PROTEIN binding , Met150 is not important for PROTEIN binding but is critical for PROTEIN1PROTEIN2 and PROTEIN binding , Met150 is not important for PROTEIN binding but is critical for PROTEIN binding , and Thr151 is not important for binding either ligand .
0	Two lines of evidence support the notion that PROTEIN and PROTEIN1 have homologous Rb-binding properties : first , several mutated PROTEIN proteins that failed to bind to T also did not associate with PROTEIN2 ; and second , both T antigen and T peptide ( amino acids 101-118 ) were able to compete with PROTEIN for binding to PROTEIN .
0	We demonstrate that PROTEIN1 surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the transporter associated with antigen processing ( PROTEIN ) and PROTEIN2 , and that PROTEIN expression is TAP-dependent and tapasin-dependent .
0	Moreover , a partial recombinant PROTEIN1 complex containing PROTEIN2 was capable of mediating in vitro transcriptional activation by the PROTEIN activation domain .
0	Expression of PROTEIN1 in stably transfected L6 cells conferred growth responses to several members of the FGF family including PROTEIN , -2 , -4 , and -6 , while PROTEIN2 IIIb-expressing cells responded only to PROTEIN .
0	PROTEIN recognizes one FGFR isoform known as the PROTEIN1 isoform or keratinocyte growth factor receptor ( PROTEIN ) , whereas PROTEIN binds well to PROTEIN , PROTEIN , and PROTEIN but interacts poorly with PROTEIN2 .
0	Remarkably , Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the PROTEIN bound to an EPO-mimetic peptide ( PROTEIN ) , suggesting that Phe93 is also important for PROTEIN1PROTEIN2-mimetic peptide ( PROTEIN ) , suggesting that Phe93 is also important for PROTEIN binding .
0	Analysis of the human PROTEIN1/human PROTEIN2 receptor binding interface at the amino acid level : proposed mechanism of interaction .
0	Furthermore , activated PROTEIN1 was not able to induce dissociation of PROTEIN2 .
0	We demonstrate that PROTEIN surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the transporter associated with antigen processing ( PROTEIN ) and PROTEIN1PROTEIN2 with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the transporter associated with antigen processing ( PROTEIN ) and PROTEIN , and that PROTEIN expression is TAP-dependent and tapasin-dependent .
0	Here , we demonstrate that PROTEIN may regulate the activity of the HIV-1 long terminal repeat through its ability to bind sequences in the PROTEIN enhancer region and to interact with the PROTEIN1 subunit , PROTEIN2 .
0	We have shown previously that Phe93 in the extracellular domain of the PROTEIN ( PROTEIN ) receptor ( PROTEIN ) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN1 ( PROTEIN2 or PROTEIN ) and no detectable binding to full-length mutant receptor expressed in COS cells .
0	Expression of PROTEIN IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including PROTEIN , -2 , -4 , and -6 , while PROTEIN1-expressing cells responded only to PROTEIN2 .
0	We have shown previously that Phe93 in the extracellular domain of the PROTEIN1 ( PROTEIN ) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN2 or PROTEIN ) and no detectable binding to full-length mutant receptor expressed in COS cells .
0	PROTEIN is a potent , tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by cyclin A-Cdk2 , cyclin E-Cdk2 , cyclin D1-PROTEIN1 , and cyclin D2-PROTEIN2 complexes .
1	Thus , Phe93 and Phe205 are important binding determinants for both PROTEIN1 and PROTEIN , even though these ligands share no sequence or structural homology , suggesting that these residues may represent a minimum epitope on the PROTEIN2 for productive ligand binding .
1	PROTEIN1 recognizes one FGFR isoform known as the PROTEIN2 isoform or keratinocyte growth factor receptor ( PROTEIN ) , whereas PROTEIN binds well to PROTEIN , PROTEIN , and PROTEIN but interacts poorly with PROTEIN .
0	Two potentially oncogenic cyclins , cyclin A and PROTEIN1 , share common properties of subunit configuration , tyrosine phosphorylation and physical association with the PROTEIN protein .Originally identified as a 'mitotic cyclin ' , PROTEIN2 exhibits properties of growth factor sensitivity , susceptibility to viral subversion and association with a tumor-suppressor protein , properties which are indicative of an S-phase-promoting factor ( PROTEIN ) as well as a candidate proto-oncogene .
0	We have shown previously that Phe93 in the extracellular domain of the PROTEIN ( PROTEIN ) receptor ( PROTEIN1 ) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN2 or PROTEIN ) and no detectable binding to full-length mutant receptor expressed in COS cells .
0	We have shown previously that Phe93 in the extracellular domain of the PROTEIN1 ( PROTEIN ) receptor ( PROTEIN ) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN2 binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( EPO-binding protein or PROTEIN ) and no detectable binding to full-length mutant receptor expressed in COS cells .
0	In vitro and in vivo experiments support the hypothesis that PROTEIN mediates the association of PROTEIN1PROTEIN2 mediates the association of PROTEIN with PROTEIN .
0	By using the growth factor dependent M-07e cell line , we found that both PROTEIN and PROTEIN1 ligands , namely : PROTEIN2 and PROTEIN , induce PROTEIN tyrosine phosphorylation .
1	PROTEIN recognizes one FGFR isoform known as the PROTEIN IIIb isoform or keratinocyte growth factor receptor ( PROTEIN ) , whereas PROTEIN1 binds well to PROTEIN2 , PROTEIN , and PROTEIN but interacts poorly with PROTEIN .
0	We have shown previously that Phe93 in the extracellular domain of the PROTEIN1 ( PROTEIN ) receptor ( PROTEIN ) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN2-binding protein or PROTEIN ) and no detectable binding to full-length mutant receptor expressed in COS cells .
